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Abstract
The world population is progressively ageing. It is estimated that by 2050, almost one-
fifth of the world population will be aged 65 years or more. Despite the significant increases
in life expectancy observed in the last century, health span remained unchanged. Therefore,
people live longer but in suboptimal conditions, which frequently lead to the development
of age-related diseases, like neurodegenerative diseases. Understanding the molecular and
cellular mechanisms underlying ageing and neurodegeneration is crucial and could provide
the means to delay, mitigate or even revert the deteriorating e↵ects associated with age-related
neurodegeneration. Recent studies have correlated increased expression of retrotransposable
elements (REs) with age, which is likely due to the tendency of RE silencing mechanisms to fail
with age. Furthermore, it was reported in flies that young individuals with a neurodegenerative
decline had premature expression of REs in their brain. However, it remains unclear whether
RE expression and mobilization are the cause or a consequence of the age-associated neuron
functional decline.
The aim of this dissertation is to determine if RE expression in the central nervous system
causes an age-associated neuronal function decline. To answer this, we developed a heterolo-
gous and naïve inducible RE system that allows specific expression of a human long interspersed
nuclear element 1 (LINE-1 or L1) in Drosophila melanogaster neurons. Negative geotaxis assays
were performed in flies aged 2, 20, and 40 days after eclosion to assess the age-associated
neurofunctional decline.
Results revealed that the forced expression of L1 in neurons throughout lifespan does not
a↵ect neuronal function. However, both in vivo and in vitro experiments failed to demonstrate
retrotransposition events in the fly. These findings suggest that additional human factors are
required in L1 retrotransposition. Future studies will focus on determining retrotransposition
xi
capacity of L1 in the fly genome.
Keywords: Ageing, Neurodegeneration, Genomic instability, Retrotransposons, L1, Drosophila
melanogaster.
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Resumo
A população humana está a envelhecer. Estima-se que em 2050, cerca de um quinto da po-
pulação mundial terá 65 anos de idade ou mais. Apesar do aumento significativo na esperança
média de vida observado no século passado, o período de vida saudável permaneceu inalterado.
Assim, as pessoas vivem mais tempo, mas em condições subótimas, que frequentemente levam
ao desenvolvimento de doenças relacionadas com a idade, como as doenças neurodegenerativas.
Estudos recentes correlacionaram o aumento da expressão de Elementos Transponíveis (ETs)
com a idade, o que provavelmente se deve à tendência dos mecanismos de repressão dos ETs
falharem com a idade. Além disso, foi relatada expressão prematura de ETs no cérebro de mos-
cas jovens com declínio da função neuronal. Contudo, permanece por esclarecer se a expressão
dos ETs e a sua mobilização são a causa ou uma consequência do declínio funcional neuronal
associado à idade.
O objetivo desta dissertação é determinar se a expressão dos ETs no sistema nervoso central
causa o declínio funcional neuronal associado à idade. Para responder a esta pergunta, desenvol-
vemos um sistema heterólogo de ETs indutível e naïve que permite expressar especificamente
um ET de humano, o long interspersed nuclear element 1 (LINE-1 or L1), nos neurónios de D.
melanogaster. Realizaram-se ensaios de geotaxia negativa em moscas com 2, 20, e 40 dias de
idade para avaliar o declínio neurofuncional.
Os resultados demonstraram que a expressão induzida de L1 nos neurónios durante a vida
da mosca não afeta a função neuronal. Contudo, os resultados obtidos em experiências in
vivo e in vitro não demonstraram evidências de eventos de retrotransposição em mosca. Estes
resultados sugerem que existem fatores humanos adicionais envolvidos na retrotransposição de
L1. Estudos futuros focar-se-ão na determinação da capacidade de retrotransposição de L1 no
genoma da mosca.
xiii
Palavras-chave: Envelhecimento, Neurodegeneração, Instabilidade Genómica, Retrotranspo-
sões, L1, Drosophila melanogaster.
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Chapter 1
Introduction
1.1 Ageing World
During the last century, there has been not only a very significant increase in life expectancy
(due to improvements in quality of life), but also a decline in population growth, especially in
the developed countries. Together, these two phenomena prompted the accelerated ageing of
the population (He et al., 2016). People aged 65 years and over represent around 8.5 % (617.1
million) of the world’s total population (7.3 billion) and this number is expected to grow in an
average annual rate of 27.1 million people (He et al., 2016). Furthermore, while Europe and
Northern America are the regions that account for the highest percentage of older people per
region (17.4 % and 15.1 %, respectively), about half (55.3 %) of the total older population of the
world lives in the Asian continent (He et al., 2016; Kinsella and He, 2009). However, with the
increase of the older population there was also an increase in several ageing-associated diseases,
namely non-communicable diseases (NCDs), such as cardiovascular and neurodegenerative
disorders, cancer, and diabetes (He et al., 2016). This suggests that ageing is a primary risk
factor for the development of NCDs.
Even though life expectancy has been increasing in the last century, the average length of
healthy life (i.e., health span) has not. People are living longer but the risk of developing NCDs,
namely neurodegenerative diseases, that further enhance deterioration and disability of the
ageing individual still remains high.
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According to Prince et al. (2014), the dementia-associated burdens (i.e., financial cost, mor-
tality, and morbidity) in people aged 60 years or more had the biggest increase (around 113 %)
among the NCDs between 1990 and 2010. In fact, it is predicted that there are currently 47
million people living with dementia worldwide and the costs associated have been estimated
in US$ 818 billion annually (Prince et al., 2016).
It is imperative to understand the molecular and cellular factors underlying ageing and
health deterioration in order to gain insight about possible interventions that may slow down,
mitigate or even revert the deteriorating e↵ects associated with ageing-related diseases.
1.2 Molecular mechanisms behind ageing
Ageing is the complex and intraindividual time-dependent functional decline that a↵ects
most living organisms (reviewed in López-Otín et al., 2013). Hence, ageing is characterized
by an intrinsic and inevitable gradual deterioration of physiological integrity, at the cellular
and organismal level, responsible for the impaired function, decreased fertility, and increased
susceptibility to death by internal and external threats (Comfort, 1964; Partridge and Mangel,
1999).
Two major groups of theories have emerged to explain the processes or mechanisms be-
hind ageing: the programmed ageing and the damage or error-based theories (reviewed in
Mercado-Sáenz et al., 2010). The former suggests the existence of an intrinsic biological pro-
gram that controls and regulates the deterioration of the structural and functional capacity of
the organism, whereas the latter defends that the observed deterioration would develop upon a
continuous accumulation of molecular and cellular damage (Magalhães, 2011; Mercado-Sáenz
et al., 2010). Currently, a combination of these two currents is preferred. In 2013, López-Otín
et al. outlined and described nine cellular and molecular mechanisms involved in ageing: ge-
nomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated
nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and
altered intracellular communication.
1.3 Genomic instability
Both endogenous and exogenous sources are continuously imposing deoxyribonucleic acid
(DNA) damage, and, consequently, challenging the integrity of the genome. These agents can
be labeled as external (or extrinsic), if they originate in the surrounding environment and
endogenous (or intrinsic), if they reside within the cell itself. Examples of external agents are
2
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ultra-violet and ionizing radiation exposure and cigarette smoke, whereas internal mutagens
encompass DNA replication errors, the formation of free radicals, and the mobilization of
transposable elements (TEs) (reviewed in Aunan et al., 2016; López-Otín et al., 2013; Vijg and
Montagna, 2017).
Genomic instability refers to a variety of events capable of causing unscheduled alterations
within the genome (reviewed in Bapat and Perera, 2007; Pikor et al., 2013). Genomic insta-
bility is caused by damage accumulation, which encompasses DNA damage, mutations, and
chromosomal alterations (Vijg and Montagna, 2017). DNA damage is related with the DNA
structure physical alteration, which includes single and double strand breaks (DSBs) of the
DNA backbone, cross-links between bases, and base modifications. Mutations involve in-
sertions, deletions, or substitutions of one or thousands of nucleotides (Vijg and Montagna,
2017). The chromosomal alterations involve gains or loss of either parts or whole chromosomes,
translocations, and inversions (Pikor et al., 2013). Mutations and chromosomal alterations are
irreversible whereas DNA damage is reversible (e.g., repairable). In order to prevent the accu-
mulation of DNA damage and to keep the viability of the cells, organisms evolved complex and
interconnected DNA repair mechanisms (reviewed in Hoeijmakers, 2001; Vijg and Montagna,
2017). Together, these highly conserved mechanisms recognize and fix almost every type of
damage inflicted to the DNA, therefore contributing for the maintenance of the genome (Lord
and Ashworth, 2012; reviewed in Hoeijmakers, 2001; López-Otín et al., 2013; Milholland et al.,
2017; Vijg and Montagna, 2017). Nevertheless, some DNA lesions unavoidably escape these re-
pair mechanisms and tend to accumulate in the genome. Additional genomic instability comes
from the generation of errors during DNA damage repair, DNA replication, or chromosomal
segregation during cell division (reviewed in Hoeijmakers, 2001; López-Otín et al., 2013; Mil-
holland et al., 2017; Vijg and Montagna, 2017). The occurrence of mutations in any of the genes
involved in the genome maintenance mechanism would further lead to a loop of increasing
instability. In addition, DNA repair mechanisms tend to fail with age, further promoting the
accumulation of damage in cells. The accumulation of genetic damage in somatic cells of an
organism plays a determinant role in ageing (Moskalev et al., 2013). In fact it has been reported
that mutations a↵ecting DNA-repair system genes are frequently associated with increased
frequency of somatic mutations and decreased lifespan in flies (Greer et al., 2013). The same
was observed for mice, which displayed a premature ageing (Dollé et al., 2006). In humans,
mutations in DNA-repair system genes were found to be correlated with human progeria syn-
drome patients (reviewed in Vijg and Montagna, 2017). The accumulation of DNA damage and
mutations has been directly implicated in ageing and in the development of neurodegenerative
3
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diseases (reviewed in Vijg and Montagna, 2017).
As mentioned above, repetitive elements, such as TEs, are another source of genome insta-
bility. In the following section, we will provide further background on TEs (subsections 1.4.1
and 1.4.2), describe how these elements can instigate genomic instability (subsection 1.4.3), and
how do the host organisms regulate TEs (subsection 1.4.4).
1.4 Transposable Elements (TEs)
1.4.1 What are TEs?
TEs were initially discovered by Barbara McClintock during her studies of Zea mays (maize)
in the mid 1940s, work that would award her a Nobel prize in 1983 (McClintock, 1950; reviewed
in Biémont andVieira, 2006; Erwin et al., 2014). While studying the inheritance of pigmentation
in maize kernels, McClintock noticed that the color patterns of kernels changed. According to
McClintock (1950), this variation was due to the mobilization of genetic units, which she named
“controlling elements”, from one locus to another. Thirty years later, Shapiro (1969) reported
that the insertion of specific DNA fragments, called insertion sequences or IS elements, into the
bacterial genome were disrupting a gene (Shapiro, 1969). It was only in 1974, that Hedges and
Jacob coined those elements as TEs or transposons after proving that DNA segments carrying
antibiotic-resistance genes are able to transpose from one DNA molecule (plasmid) to another
(chromosome).
Today, we know that TEs, also known as jumping genes, are discrete and moderately repeti-
tive interspersed DNA sequences capable of moving within a host genome (reviewed in Biémont
and Vieira, 2006). TEs can be found in the genome of organisms from all three domains of life
(Figure 1.1) (reviewed in Elbarbary et al., 2016; Haren et al., 1999; Huang et al., 2012; Piégu
et al., 2015). The percentage of TEs present in the genome of an organism seems to be positively
correlated with genome size. For instance, the genomes of Escherichia coli (0.0046 pg; 1 pg =
~1 Gbp of DNA), D. melanogaster (0.18 pg), Homo sapiens (3.5 pg), and Z. mays (5.0 pg) are
composed by 0.3, 22, 45, and 60 % of TEs, respectively (Alzohairy et al., 2013; Biémont and
Vieira, 2006). There are even some cases in plants where TEs make up to 90 % of its genome
(reviewed in Ayarpadikannan and Kim, 2014).
1.4.2 TE Classification
TEs can be classified as type I or type II according to their capacity to mobilize via ribonu-
cleic acid (RNA) or DNA intermediates, respectively (Figure 1.2) (reviewed in Ayarpadikannan
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Figure 1.1: The composition of TE di↵ers between di↵erent taxa. The circle charts portray
the relative composition of di↵erent TE classes in each species genome. The evolutionary
relationship between species is represented by the phylogenetic tree in the center. LTR - Long
Terminal Repeat, LINE - Long Interspersed Nuclear Element, SINE - Short Interspersed Nuclear
Element (reproduced from Huang et al., 2012).
and Kim, 2014; Huang et al., 2012; Mita and Boeke, 2016). Type I TEs mobilize using an RNA in-
termediate, generating new copies in the genome through a process termed retrotransposition
(copy-and-paste mechanism). They are called retrotransposable elements (REs), retrotrans-
posons, or retroelements. On the other hand, type II TEs mobilize via DNA intermediates,
excising themselves and re-integrating elsewhere in the genome (cut-and-paste mechanism).
Type II TEs are termed DNA transposons (reviewed in Huang et al., 2012; Mita and Boeke,
2016).
REs can be separated into two di↵erent subtypes according to their structural features. REs
flanked by long terminal repeat (LTR) (i.e., repeated sequences of 300 to 1000 bp) are designated
LTR retrotransposons, whereas REs without LTRs are entitled non-LTRs retrotransposons (re-
viewed in Huang et al., 2012; Mita and Boeke, 2016). Non-LTRs retrotransposons are separated
into two classes: long interspersed nuclear element (LINE)s and short interspersed nuclear ele-
ment (SINE). LINEs and SINEs di↵er in size and structure. LINEs are about 6 kb long, encode
the proteins required for the retrotransposition, and are transcribed by a RNA polymerase II,
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Figure 1.2: Classification and organization of TEs in the human genome. Transposable El-
ements (TEs) can be divided into type I or type II according to whether they propagate via
RNA or DNA intermediates, respectively. Type I TEs are subdivided into Non-LTR and LTR
transposons according to structural features. Non-LTR TEs are divided into di↵erent classes
according to their functional domains, and consequently into di↵erent families (2 examples of
each were given). Genome percentage is relative to the human genome. Full-length canonical
structures are shown with corresponding polymerases and polyadenylation signals. LTR- Long
Terminal Repeat, SINE - Short Interspersed Nuclear Element, LINE - Long Interspersed Nuclear
Element, ERV - Endogenous Retrovirus (adapted from Ishak et al., 2018).
whereas SINEs are ~300 bp long, do not encode proteins, and are transcribed by a RNA poly-
merase III. Examples of LINEs and SINEs are the long interspersed nuclear element 1 (LINE-1 or
L1), a family of LINEs widely present in mammals, and Alu, a primate-specific family of SINEs,
respectively.
Today, approximately 3, 8, 11, and 20 % of the human genome correspond to DNA trans-
posons, LTR retrotransposons, SINEs, and LINEs, respectively (Lander et al., 2001).
1.4.3 Impact of TEs on genome
1.4.3.1 TEs as mutagens
Though McClintock had previously described TEs as “controlling elements”, this idea dis-
appeared by the 60’s. At that time, TEs were seen as functionless genomic parasites given their
capacity to propagate throughout the genome at the cost of the host and no known selected
function. This was also the reason why they were considered to be “selfish DNA” and “junk
DNA” (reviewed in Sotero-Caio et al., 2017). The ability to disseminate across the genome pro-
vides TEs with an intrinsic propensity to impact the genome at both structural and functional
level (reviewed in Seidl and Thomma, 2017). This influence on the genome can range from
local instability to large-scale structural variations. Hence, TEs constitute a significant source
of mutations in the human genome that can potentially cause diseases. Since REs comprise the
majority of TEs in the human genome, we will concentrate on the mutagenic ability of REs.
The mobilization of REs represent a threat to the hosts because it can impact the genome
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and the genome structure. Insertional mutagenesis, transduction of flanking sequences, ectopic
recombination, modulation of gene expression, and DNA DSBs formation are some of the
examples of how REs can reshu✏e the genome and alter gene expression (Figure 1.3). Below,
we describe in more detail some of these mechanisms, focusing mostly on L1 and Alu e↵ects,
which are the most active TEs in the human genome.
A   Insertional mutagenesis B   Insertion-mediated deletions C   Creating and repairing DNA double-strand breaks
F   Ectopic recombination G   TransductionE   Gene conversionD   Microsatellite seeding
(TA)n
Figure 1.3: Mechanisms through which REs can a↵ect the host genome. Insertion of a TE
(blue) into a new location (grey) may cause gene (A) disruption or (B) deletion (light grey) of the
site. (C) TE endonuclease (orange) may create and L1 may repair DSBs. (D) Homopolymeric
tracts endogenous to retrotransposons may generate microsatellites. (E) Non-reciprocal recom-
bination between homologous transposons (orange and blue), that can lead to TE activation or
deactivation.(F) Non allelic recombination may lead to deletions or duplications. (G) During
retrotransposition, the flanking regions may be co-retrotransposed with the TE. (reproduced
from Cordaux and Batzer, 2009).
REs cause mutations by inserting themselves into functional sequences such as promoters,
exons, and enhancers in a process termed insertional mutagenesis (Figure 1.3.A). Such inser-
tions are expected to severely compromise gene function whether it is by interfering with gene
transcription, or by interfering with the functionality of a protein. Moreover, the insertion of
these elements into the intronic region of a gene can culminate in exon skipping or alternative
splicing of that transcript. Besides causing local genomic instability, the insertion of REs into
new sites in the genome may produce target site deletions that can range from 1 bp to 130
kb or more (Figure 1.3.B). Even though it happens more rarely than insertional mutagenesis,
insertion-mediated deletions do occur and have been reported to occur naturally in the human
genome. For example, L1 integration into the pyruvate dehydrogenase complex – component X
- gene led to a 46 kb deletion that culminated in pyruvate dehydrogenase complex deficiency in
a human patient (reviewed in Goodier and Kazazian, 2008; Han and Boeke, 2005).
DSBs are among the most deleterious types of genomic damage that can occur in the genome
because the DSB-repair mechanisms have a large rate of error. This introduction of errors upon
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repair, frequently leads to loss of genetic information and, in some cases, instigates chromo-
somal rearrangements (Figure 1.3.C) (Longhese et al., 2006). L1 has been linked with the
formation of DSBs (Gasior et al., 2006; reviewed in Cordaux and Batzer, 2009; Goodier and
Kazazian, 2008). While overexpressing L1 in mammalian cells, Gasior et al. (2006) observed
an unexpected increased number of DSBs that did not match the number of real L1 insertions.
This observation suggested that L1 was able to cleave DNA independently of retrotransposi-
tion. Furthermore, these results were later shown to be consistent with the findings that L1
overexpression led to apoptosis and senescence (a state of permanent arrest of the cell cycle)
(Belgnaoui et al., 2006; Gasior et al., 2006; Haoudi et al., 2004; Wallace et al., 2008b; reviewed
in Goodier and Kazazian, 2008; Richardson et al., 2015). Interestingly, Wallace et al. (2008b)
showed that open reading frame (ORF) 2 protein (ORF2p), one of the L1 proteins that has
endonuclease activity, alone was su cient to prevent between 50-60 % of cellular prolifera-
tion in human cells. The authors further suggested that the ORF2p-mediated toxicity would
be independent of retrotransposition, and that mutation of either the endonuclease or reverse
transcriptase domain would lead to a decreased toxicity (Wallace et al., 2008b). Thus, L1 is
considered to be one of the sources of DNA DSB formation and, consequently, of genomic insta-
bility (reviewed in Cordaux and Batzer, 2009; Goodier and Kazazian, 2008; Richardson et al.,
2015).
Post-integration recombination events between genomic retrotransposons are behind the
large-scale structural variation in the genome (Figure 1.3.F). The vast copy number of L1
and Alu elements instigate the recombination between non-allelic homologous elements (i.e.,
ectopic recombination), which can lead to genomic deletions, duplications, inversions or even
translocations (reviewed in Cordaux and Batzer, 2009; Goodier et al., 2000; Richardson et al.,
2015). Indeed, several studies have identified the occurrence of deletions associated with Alu-
mediated recombination as the cause of certain cancers and genetic disorders (Callinan and
Batzer, 2006). Albeit at a low frequency, deletions associated with L1-mediated recombination
have also been reported to cause diseases (reviewed in Cordaux and Batzer, 2009).
Sometimes, the genomic regions that flank REs can be co-retrotransposed with them in a
process termed (5’ or 3’) transduction (Figure 1.3.G). 5’ transduction events originate when
transcription is initiated from a di↵erent promoter which resides upstream of an active non-LTR
retrotransposons. Chen et al. (2006) proved that 5’ transduction events do happen and that it can
lead to deleterious e↵ects. Contrarily, due to the presence of inherently weak polyadenylation
signals in the 3’ untranslated region (UTR) of non-LTR retrotransposons, 3’ end processing
machinery often bypasses this signal, resulting in the co-transposition of downstream sequences
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(3’ transduction). Thus, up until 20% of the time, a second downstream poly(adenine (A)) signal
is utilized, leading to the insertion of that 3’ flanking genomic DNA into a new chromosomal
location (Holmes et al., 1994). Hence, transduction events can lead to exon shu✏ing and
creation of new genes (by mobilizing exons and promoters) (reviewed in Goodier and Kazazian,
2008; Richardson et al., 2015).
1.4.3.2 TEs as an evolutionary driving force
The idea that TEs are important contributors to genetic innovation, and possible drivers
of genome evolution was first proposed by Barbara McClintock (Biémont, 2010; McClintock,
1984), but started gaining more widespread acceptance when the human genome reference se-
quence revealed that half of the human genome was comprised of TEs (Lander et al., 2001). TEs
were then considered double-edged swords that despite having a detrimental e↵ect at the indi-
vidual level by promoting genomic instability, have been a massive driving force in evolution
and biodiversity (reviewed in Jurka et al., 2007). For millions of years, TEs have continuously
propagated and accumulated in the genome. The presence of stressors and other environmental
stimuli or conflicts triggered several outbursts of activity of certain TEs throughout evolution.
Those TE outbursts were crucial for their amplification in the genome, and led to the increase
in the genome size (reviewed in Horváth et al., 2017). Many of these new insertions were not
complete, thus yielding remnants of TEs unable to mobilize (molecular fossils). Several of these
fossils are currently being used to determine inter-genetic variation in forensic sciences while
others were co-opted by the host to serve their cellular functions (reviewed in Jurka et al., 2007).
Below, we describe in more detail some mechanisms through which the mobilization of TEs can
be constructive and advantageous to the host cell, focusing mostly on REs.
In some cases, the accumulation of mutations led to the neofunctionalization (i.e., domes-
tication or co-option) of the inserted elements. Certain TEs acquired di↵erent functions that
often brought phenotypic benefits to the host (Gould and Vrba, 1982; reviewed in Casola et al.,
2007; Joly-Lopez and Bureau, 2018). Consequently, the domesticated TEs started evolving un-
der phenotypic rather than self-replicative selection. There are several studies reporting that
some TEs were actually co-opted by the host. A clear example of TE neofunctionalization is the
mechanism of telomere maintenance in D. melanogaster. Drosophila does not have telomerase,
the enzyme responsible for maintaining telomere length in other eukaryotes, like mammals.
Instead, repeated transpositions of Drosophila non-LTR REs maintain the chromosome ends,
preventing their shortening. Despite being able to mobilize to other places, these REs show
a preference for the end of the chromosomes and are rarely found in other genomic regions
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(reviewed in Jangam et al., 2017; Pardue and DeBaryshe, 2011a; Pardue and DeBaryshe, 2011b).
Another example whereby TEs have contributed to genome evolution is at the base of the
vertebrate adaptive immune system: V(D)J recombination (Jangam et al., 2017; Thompson,
1995). Briefly, V(D)J recombination is the process of somatic recombination that occurs during
T and B cell development, where several segments of (Variable, Diversity and Joining) genes
are assembled arbitrarily to produce countless unique receptors, capable of recognizing di↵er-
ent molecules (reviewed in Lewis, 1994). Recombination activating gene 1 and 2 (RAG1 and
RAG2) are the enzymes involved in the segment rearrangement and recombination. The recom-
bination signal sequences that flank the segments are crucial to determine which sequences
will be cleaved and joined (reviewed in Lewis, 1994). Both RAGs and the recombination sig-
nal sequences are thought to be derived from the transposase and terminal inverted repeats
sequences of DNA transposons (Kapitonov and Jurka, 2005; Kapitonov and Koonin, 2015; re-
viewed in Carmona and Schatz, 2017). Curiously, the clustered regularly interspaced short
palindromic repeats (CRISPR)-CRISPR-associated system (Cas) system, the adaptive immune
system of prokaryotes, also seems to result from TE co-option ( Jangam et al., 2017).
1.4.4 Regulation of TEs
Given themutagenic potential and the associated deleterious consequences of a retrotranspo-
sition event on the genome, hosts evolved transcriptional and post-transcriptional mechanisms
to regulate or even suppress RE activity in both somatic and germ cells (reviewed in Ishak
et al., 2018). Although some TE silencing mechanisms in mammals, like the P-element induced
wimpy testis (PIWI) pathway, are more specific to the germline, there are others, like DNA
and histone methylation, that are also active in somatic cells. The outcome of the cooperation
between the di↵erent repressing mechanisms is the continuous and dynamic establishment of
silencing marks, which are maintained and require the cooperative action of many di↵erent
proteins (Castro-Diaz et al., 2014; Rowe et al., 2013; reviewed in Slotkin and Martienssen, 2007).
1.4.4.1 Transcriptional REs silencing
Transcriptional strategies of RE silencing include chromatin modifications through DNA
methylation and histone modification (reviewed in Cardelli, 2018) and KRAB Zinc-Finger pro-
teins (reviewed in Richardson et al., 2015; Yang and Wang, 2016). We refer to DNA methylation
here as the process in which the fifth carbon of a cytosine residue receives a methyl group to
form a 5-methylcytosine. In vertebrates, DNA methylation seems to be more restricted to CpG
sites, which are repetitive sequences made of dinucleotides of cytosine preceding guanines,
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whereas in other eukaryotes, like plants, non-CpG cytosine are also targeted (Holliday and
Pugh, 1975; reviewed in Cardelli, 2018). Additionally, DNA methylation is a defense mech-
anism that promotes the inheritance of TE silencing since the methylation pattern is copied
to the new strand upon DNA replication (reviewed in Long et al., 2017). The use of DNA
methylation as a TE activity repressing mechanism is conserved in vertebrates, fungi, and some
plants (reviewed in Cardelli, 2018). Though invertebrates do not use DNA methylation as a
defense mechanism against TEs, they possess other mechanisms that e↵ectively silence these
elements (Siomi et al., 2008; Yang and Wang, 2016). The L1 internal promoter comprises a
CpG island which is typically highly methylated (Hata and Sakaki, 1997). In humans, DNA
methylation is initially established in primordial germ cells and maintained throughout the
life of an organism. The maintenance of this epigenetic repression is thought to control the
expression of REs, namely L1 (and LTR retrotransposons in mice), in somatic tissues and germ
cells (reviewed in Richardson et al., 2015; Yang and Wang, 2016).
Just like DNA methylation, some types of histone modifications can promote repressive
chromatin states that suppress TE activity (Rowe and Trono, 2011; reviewed in Castro-Diaz et
al., 2015). Histone methylation and deacetylation are especially important in tissues where the
DNA is hypomethylated, such as in embryonic stem cells (Garcia-Pérez et al., 2010; reviewed
in Garcia-Pérez, 2016; Goodier and Kazazian, 2008). Methylation of histone H3 at lysine
9 (H3K9) signals for transcriptionally repressive and inactive chromatin. H3K9 is typically
associated with nucleosomes containing TEs. Hence, the occurrence of deleterious mutations in
the histone modifying genes result in TE reactivation. An example would be the histone H3K9
methyltransferase gene, Suv39, which when mutated, induces TE overexpression in mouse
embryonic stem cells (Martens et al., 2005; reviewed in Slotkin and Martienssen, 2007).
Interestingly, the involvement of PIWI proteins and PIWI-interacting RNAs (piRNAs) in the
regulation of de novomethylation of REs in the animals germline has been suggested (reviewed
in Yang and Wang, 2016). Briefly, PIWI proteins are small RNA binding proteins, belonging to
the Argonaute family of proteins (reviewed in Castel and Martienssen, 2013; Richardson et al.,
2015; Yang and Wang, 2016). PIWI proteins are typically gonad-specific but a somatic role has
also been described (reviewed in Castel and Martienssen, 2013; Siomi et al., 2008; Zuo et al.,
2016). The RNAs these proteins interact with are typically single-stranded and have between
23 and 31 nucleotides (reviewed in Castel and Martienssen, 2013; Slotkin and Martienssen,
2007; Zuo et al., 2016). Briefly, piRNAs are transcribed from genomic piRNA clusters, exported
to the cytoplasm and loaded into PIWI-containing complexes to be used as guides to degrade
the complementary TE messenger RNAs (mRNAs) by endonucleolytic processing (reviewed in
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Garcia-Pérez, 2016; Goodier and Kazazian, 2008; Richardson et al., 2015; Yang andWang, 2016).
The cleavage of TEs often leads to the formation of additional piRNAs that target the same ele-
ment (Slotkin and Martienssen, 2007; Yang and Wang, 2016). Although the piRNA pathway is
conserved in animals, it operates di↵erently in mice (mammals) and in the fruit fly (reviewed
in Castel and Martienssen, 2013). During early development, there is a global derepression of
transposons in the mouse male germ line due to DNA demethylation. The DNA methylation
pattern is then re-established via the PIWI pathway, in which the piRNAs direct PIWI proteins
to transposon enriched regions (reviewed in Castel and Martienssen, 2013). For instance, the
mammalian Rasgfr1 locus, which is usually (DNA) methylated, is located downstream of an
LTR retrotransposon whose transcript is targeted by piRNAs (that originate from a genomic
piRNA cluster that has a copy of an LTR) during de novomethylation in the early development.
The LTR is then methylated and thought to facilitate the spreading of methylation to the Rasgfr1
locus (reviewed in Castel and Martienssen, 2013). Other studies have shown that mice with
PIWI proteins mutated exhibit a similar phenotype to mouse lacking a DNA methyltransferase
(that promotes the establishment of DNA methylation patterns) (Bourc’his and Bestor, 2004).
Besides being unable to undergo meiosis properly, these mice are characterized by DNA hy-
pomethylation of the TE-enriched genomic regions, uncontrolled expression, and propagation
of (L1 and LTR) REs in the mouse male germline (Aravin et al., 2008; reviewed in Richardson
et al., 2015). Recent studies have shown that in the spermatogonia of adult mice with defects in
PIWI proteins, L1 remain repressed via H3K9methylation (Di Giacomo et al., 2013; Di Giacomo
et al., 2014). In Drosophila ovaries, piRNA-mediated silencing of transposons occurs only via
H3K9 methylation (Sienski et al., 2012). In the follicle cells, one piRNA cluster is expressed and
piRNAs against TEs from the gypsy family (LTR), which is very active in Drosophila genome,
are made. Once the piRNAs interact with the PIWI proteins, there is transcriptional silencing
of gypsy REs in the nucleus. In the oocyte, on the other hand, there is expression of several
piRNA clusters, resulting in the silencing of several active transposons through H3K9 methy-
lation. The presence of PIWI proteins in the nucleus and its interacting RNAs is crucial to
the heterochromatinization of these transposons (Klenov et al., 2011, reviewed in Castel and
Martienssen, 2013; Yang and Wang, 2016).
1.4.4.2 Post-transcriptional RE silencing
Post-transcriptionalmechanisms include the piRNA pathway, small interference RNA (siRNA),
microRNA (miRNA), alternative RNA splicing of REs, and premature polyadenylation of REs.
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Both RE RNA splicing and premature polyadenylation are considered to be secondary mecha-
nisms of REs silencing and will not be the focus of this section.
Besides targeting TE-enriched DNA regions for DNA and histone methylation, the piRNA
pathway also mediates the cleavage of active transposon transcripts, namely in flies (Zhang
et al., 2015; reviewed in Castel and Martienssen, 2013; Levin and Moran, 2011; Slotkin and
Martienssen, 2007; Yang and Wang, 2016). As mentioned in the previous section (subsubsec-
tion 1.4.4.1), the degradation process allows the formation of additional piRNAs, which in turn
enables the perpetuation of this e↵ective transposon defense cycle. This cycle is termed "ping-
pong" amplification cycle (reviewed in Richardson et al., 2015). In Drosophila, the disruption
of piRNA pathways leads to derepression of retrotransposons in the male germline (reviewed
in Goodier and Kazazian, 2008). Moreover, the deletion of RNAs in a piRNA cluster in mice
resulted in the overexpression of L1 in the spermatocytes (Xu et al., 2008; reviewed in Goodier
and Kazazian, 2008).
Another class of small RNAs involved in the silencing of TEs is the siRNA. InDrosophila, siR-
NAs are called endogenous short interfering RNAs (esiRNAs) and are involved in somatic tissue
silencing of TEs (Li et al., 2013; Siomi et al., 2008). Unlike piRNAs, esiRNAs are 21 nucleotides
long and are ubiquitously expressed. The bidirectional transcription of retrotransposons (and
other repetitive sequences) leads to the formation of double-stranded RNAs whose sense and
antisense strands originate esiRNAs in a manner dependent on Dicer2, a double stranded RNA
ribonuclease (Ghildiyal et al., 2008; Siomi et al., 2008). Once assembled to the specific PIWI
protein, esiRNAs target the transcript of the target transposon for cleavage and degradation
(Siomi et al., 2008). Moreover, endogenous siRNAs also silence transposons in mice and hu-
mans, since the knockout of the homolog Dicer in both of them leads to the overexpression of
certain REs (like L1) in the mouse ovaries, HeLa cells, and HEK cells (Watanabe et al., 2008;
Yang and Kazazian, 2006).
An additional mechanism of TE regulation through small RNA is carried out by miRNAs.
The microprocessor is a nuclear complex, that recognizes the primary miRNA (pri-miRNA)
with RNA hairpin structures, cleaves, and processes the pri-miRNA to pre-miRNA (reviewed
in Garcia-Pérez, 2016). After being exported to the cytoplasm, the pre-miRNA is further
cleaved into mature miRNAs which will direct argonaute proteins - and the associated complex
- to the target sequence in cellular RNAs. Consequently, these RNAs are either degraded or
untranslatable. In vitro studies have shown that the microprocessor possesses the ability to
recognize structural RNA domains in and bind specifically to L1 and Alu transcripts and cleave
them (reviewed in Garcia-Pérez, 2016; Goodier and Kazazian, 2008; Richardson et al., 2015).
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Together, all these mechanisms constitute a complex yet very successful network of repres-
sors that control the mobilization of TEs in both germ and somatic cells.
1.4.5 Active TEs in the genome
1.4.5.1 Active TEs in Drosophila melanogaster (fruit fly)
TEs constitute around 23 % of the D. melanogaster genome. This represents more than
36,810 copies of approximately 100 di↵erent TEs (Mackay et al., 2012; reviewed in Barrón et al.,
2014; McCullers and Steiniger, 2017; Petrov et al., 2003). However, only around one-third of
these are thought to be full length and active due to the accumulation of errors introduced
during replication and integration of truncated elements (Hoskins et al., 2002; Kaminker et al.,
2002). The active elements in the Drosophila genome encompass DNA transposons (16 %),
LTR retrotransposons (45 %), and non-LTR retrotransposons (21 %) (Kaminker et al., 2002;
reviewed in McCullers and Steiniger, 2017). Elements from all these classes have been shown
to be active and mobile not only in the fly germline, but also in somatic tissues like the brain
(Li et al., 2013; Perrat et al., 2013). Among the TEs that are expressed and mobile in the brain
are the DNA transposons P-element and transib, the LTR retrotransposons gypsy, copia, and
roo (being roo the most abundant TE in the fly genome), and the LINE-like elements (non-
LTR retrotransposons) I-element and R2 (Hoskins et al., 2002; Kaminker et al., 2002; Li et al.,
2013; Perrat et al., 2013; reviewed in Waddell et al., 2014). Cell type-specific gene expression
profiling data showed that even though REs are expressed all over the brain, their expression is
substantially higher in a particular subset of neurons in the mushroom body (Perrat et al., 2013).
Deep sequencing experiments further revealed that the expressed REs are mobile and result
in de novo insertions all over the brain. However, there seems to be a higher frequency of the
mobilization of these elements in the mushroom body-specific neurons and about half of those
insertions were near identified genes (Perrat et al., 2013). The authors further showed that the
piRNA-mediated RE silencing pathway, that represses REs in the fly germline, was also active
in the brain, albeit at reduced levels in the mushroom body-specific neurons, thus explaining
the increased expression of REs in those neurons. Some non-LTR elements are also known
to be ubiquitously expressed and mobile given their involvement in Drosophila chromosomes
telomere maintenance (reviewed in Pardue and DeBaryshe, 2011b).
1.4.5.2 Active TEs inMus musculus (mouse)
Unlike what happens in D. melanogaster, active TEs in mammals are restricted to specific
elements of certain classes. TEs constitute 40 % of the mouse genome (Waterston et al., 2002).
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REs are the only known active TEs in the mouse genome. The active REs includes elements
from both LTR and non-LTR retrotransposons. Among the LTR retrotransposons, the most
successful LTR element is the still active MaLR (with 388,000 copies). Other abundant and
very active LTR retrotransposons are the intracisternal-A particles (abbreviated as IAP) and the
early-transposons (ETn). In fact, almost 15 % of spontaneous mouse mutants have one of these
elements inserted in an allele (Waterston et al., 2002). The active non-LTR retrotransposons
are the L1 (599,000 L1 derived sequences, comprising ~19 % of the mouse genome) and four
di↵erent family of SINEs (in a total of 1,498,000 copies corresponding to ~8 % of the mouse
genome) (Waterston et al., 2002). It is estimated that of the more than 599,000 L1s, only around
3,000 are full-length and competent for retrotransposition (Goodier et al., 2001; Waterston et al.,
2002).
1.4.5.3 Active TEs in Homo sapiens sapiens (human)
Although approximately 45 % of the human genome is occupied by TEs or TE-derived
sequences, only a few elements remain active (Lander et al., 2001; Mills et al., 2006; Waterston
et al., 2005). Similarly to the mouse genome, almost every TEs in the human genome are either
DNA transposons (~3 %), LTR retrotransposons (~8 %), and non-LTR retrotransposons (~35
%) (Lander et al., 2001). DNA transposons are currently thought to be inactive and incapable
of mobilizing. Albeit recent studies reported transposition events of a specific subfamily of
LTR retrotransposons, it is believed that LTR elements in general are on a path to extinction.
The most active elements in the human genome are L1 (LINE, ~17 %) and Alu (SINE, ~11 %)
(Lander et al., 2001; Mills et al., 2007). Several studies have shown that REs are active in the
human genome in somatic and germline cells (Akagi et al., 2008; Belancio et al., 2010; Coufal
et al., 2009; Dewannieux et al., 2003; Evrony et al., 2012; Halling et al., 1999; Kazazian et al.,
1988; Moran et al., 1996; Muotri et al., 2005; Upton et al., 2015; reviewed in Mills et al., 2007).
Below we describe L1 and Alu elements in more detail.
1.4.5.3.1 LINE-1 (L1) retrotransposons
L1s have been present in mammalian genomes for more than 160 million years and it is
speculated that L1 had a key role in the diversification and evolution of this group of animals
(reviewed in Richardson et al., 2015). Indeed, there was a burst of L1 activity in the human
genome after the divergence of the ancestral mouse and human lineages (around 65-75 million
years ago) (Lander et al., 2001). This burst led to a substantial increase in the number of L1-
derived sequences present in the human genome. Today, more than 500,000 copies of L1 account
for 17 % of the human genome (Lander et al., 2001, reviewed in Faulkner and Garcia-Perez,
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2017). Of the more than 500,000 L1-derived sequences, only 80 to 100 (~0.02 %) are functional
and capable of accomplishing retrotransposition (retrotransposition competent (RC)). The
remaining copies (~99.8 %) either accumulated mutations or are truncated, and therefore are
incapable of undergoing retrotransposition events (Brouha et al., 2003; Hardies et al., 1986;
Voliva et al., 1983). For this reason, they are considered molecular fossils. Since these estimates
are based solely on the euchromatic portion of the genome, the number of RC-L1s is likely
underestimated (Brouha et al., 2003; Lander et al., 2001).
Every known RC-L1 belongs to one out of the sixteen L1 subfamilies, the subfamily PA1,
and because they are human-specific L1s, they have been termed L1Hs. The majority of the
currently active L1Hs belongs to a specific small subset of L1s, denominated Transcribed group
a subset (Ta-subset) (Beck et al., 2010; Boissinot et al., 2000; Huang et al., 2010; Iskow et al.,
2010; Skowronski et al., 1988). In fact, the bulk of retrotransposition in the human population
is carried out by only 8 to 10 % of the RC-L1s and practically all of them belong to the Ta-subset
(Brouha et al., 2003; Sassaman et al., 1997; Skowronski et al., 1988). These highly active elements
are referred to as "hot" L1s (Brouha et al., 2003). Functional studies performed by Beck et al.
(2010), Iskow et al. (2010), and Huang et al. (2010) in which they used di↵erent approaches to
map the human L1s further corroborated the Ta-subset L1s as the main responsible for the bulk
of retrotransposition. A typical RC-L1s is 6 kb long and encompasses a 5’UTR, in which resides
an internal promoter with a CpG island, two non-overlapping ORFs, and a 3’UTR (Figure 1.2).
The two ORFs, ORF1 and ORF2, are 63 bp apart from one another.
L1 ORF1 and ORF2 encode di↵erent proteins, ORF1p and ORF2p, which are crucial for
the retrotransposition process of L1. ORF1p is a 40-kDa RNA-binding protein that binds to
L1 transcripts, stabilizing them, whereas ORF2p is a 150-kDa multifunctional protein with
endonuclease and reverse transcriptase activities. Together, these two proteins promote the
retrotransposition of L1 in cis through a process designated target primed reverse transcription
(TPRT) (reviewed in Goodier and Kazazian, 2008; Thomas et al., 2012).
L1 retrotransposition initiates with transcription of L1 and transportation of the mRNA
to the cytoplasm where translation of ORF1p and ORF2p occurs. Once translated, ORF1p
and ORF2p bind to the L1 mRNA molecule from which they were coded, in cis, to compose a
ribonucleoprotein particle (RNP) complex. Then the RNPs enter the cell nucleus and reach the
gDNA, where the TPRT integration process begins. In TPRT, the endonuclease domain of the
ORF2p recognizes and nicks the target DNA, generating a free 3’-hydroxyl end that is used by
the reverse transcriptase domain to prime reverse transcription of L1mRNA, and, consequently,
integrate L1. This mechanism of retrotransposition generates a small target-site duplication of
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7-20 bp that flanks the new insertions. Reverse transcription frequently terminates prematurely
through a pathway termed abortive retrotransposition and results in the formation of many (5’-)
truncated and nonfunctional insertions (Gilbert et al., 2005). According to Lander et al. (2001),
the majority of LINE-derived repeats are shortened, being on average only 1 kb long. Even
though this is one of the most well studied mechanisms of retrotransposition, there are still
details that remain unclear, such as the mechanism through which the RNP complexes enter
the cell nucleus and the exact function of ORF1p in retrotransposition (reviewed in Thomas
et al., 2012).
L1 was first shown to be active and able to retrotranspose in neurons in a pioneer work by
Muotri et al., 2005, in which rat hippocampus neural stem cells were transfected with an engi-
neered human L1 carrying a retrotransposition reporter cassette and then di↵erentiated into
neural progenitor cells. Additionally, the ability of L1 to retrotranspose in neurons was further
corroborated by in vivo studies performed in mice. This work demonstrated not only that L1
is capable of inserting de novo copies in the genome of hippocampal neurons during develop-
ment, but also that the new insertions can a↵ect the neuronal expression of neuronal genes,
and therefore influentiate the neuronal cell fate (Muotri et al., 2005). Interestingly, Muotri et al.
(2005) also revealed that L1 transcription seems to inversely correlate with the presence of
an L1 repressor, Sox2. During a certain period in the course of neuronal di↵erentiation, Sox2
expression is decreased, chromatin undergoes remodelling, and L1 is expressed. Since then,
several studies have corroborated not only that L1 retrotransposes in the central nervous system
(CNS), but also in other somatic tissues, albeit at a lower frequency (Baillie et al., 2011; Belancio
et al., 2010; Coufal et al., 2009; Evrony et al., 2012; Evrony et al., 2015; Hazen et al., 2016; Macia
et al., 2017; Muotri et al., 2009; Muotri et al., 2010; Sur et al., 2017; Upton et al., 2015).
1.4.5.3.2 Alu retrotransposons
There are three di↵erent families of SINEs in the human genome, albeit only one, the Alu
family, is currently active (Lander et al., 2001). Alu elements, named after an internal AluI
restriction enzyme recognition site, are primate-specific SINEs that have been present in the
hominid lineage for the past 65 million years (reviewed in Batzer and Deininger, 2002). A burst
in the retrotransposition of Alu elements occurred 40 million years ago and contributed for
approximately 80% of theAlu copy number currently present in the human genome. Withmore
than 1,100,000 copies in the human genome (corresponding to ~10 % of the human genome),
Alu elements are the most successful family of TEs in the human genome (reviewed in Ade et al.,
2013; Batzer and Deininger, 2002; Cordaux and Batzer, 2009; Lander et al., 2001). However,
not every Alu is capable of undergoing retrotransposition mainly due to the accumulation of
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mutations that influence its RNA structure and protein binding capacity (Bennett et al., 2008;
Deininger, 2011).
Alu elements can be classified into three major subfamilies, J, S, and Y, according to their
evolutionary age. Alu Y is the youngest and the only active subfamily in the human genome,
accounting with being responsible for the bulk of Alu retrotransposition in the human genome
(Ade et al., 2013; Bennett et al., 2008). Besides being the most dominant Alu elements, Alu Ya5
and Alu Yb8 are highly polymorphic and therefore contribute for the diversification of human
population (Ade et al., 2013; Bennett et al., 2008; Burns and Boeke, 2012).
A typical human Alu is a 280 bp dimer, which is ancestrally derived from 7SL RNA (Ullu
and Tschudi, 1984; reviewed in Deininger, 2011). 7SL RNA is part of the signal recognition
particle, a universally conserved ribosome-protein-RNA complex involved in protein sorting
(Walter and Blobel, 1982). Human Alu elements are composed by a left and a right monomer
divided by a short centrally located A-rich sequence (reviewed in Ade et al., 2013; Burns and
Boeke, 2012; Cardelli, 2018; Deininger, 2011; Richardson et al., 2015). Alu elements also have a
poly(A) region in their 3’ terminal sequence, which can influence not only their expression, but
also their ability to be retrotransposed (Roy-Engel et al., 2002). The left monomer comprises
two conserved sequences named box A and box B that correspond to internal RNA polymerase
III binding sites, constituting an internal RNA polymerase III promoter. (reviewed in Ade et al.,
2013; Burns and Boeke, 2012; Cardelli, 2018; Richardson et al., 2015).
Alu elements, and SINEs in general, are non-autonomous retrotransposons because they do
not encode the proteins necessary to mediate their retrotransposition. Therefore, Alu elements
depend on other retrotransposons proteins, L1 proteins in particular, to be retrotransposed.
Although L1 ORF1p enhances the retrotransposition e ciency of Alu, ORF2p is su cient to
promote new insertions of Alu in the genome (Dewannieux et al., 2003; Wallace et al., 2008a).
Once transcribed, Alu mRNAs assemble into ribonucleoprotein complexes that are thought
to help direct and promote the association between Alu mRNAs and ribosomes (Ade et al.,
2013; Deininger, 2011). The Alu complexes encompass the binding of the protein heterodimer
SRP9/14 and polyA-binding proteins (PABPs) (reviewed in Deininger, 2011). If any of the
Alu mRNA associated ribosomes translates an L1 mRNA, Alu mRNA would have privileged
access to ORF2p as soon as it finishes being translated. Hence, upon ORF2 translation from
L1 mRNAs, Alu mRNAs hijack the ORF2p to mediate their retrotransposition in trans. Like
L1, Alu elements integrate the genome via TPRT process and are also flanked by target-site
duplications (reviewed in Ade et al., 2013; Deininger, 2011).
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Similarly to L1, Alu elements have also been shown to be active and able to be retrotrans-
posed (Wallace et al., 1991; reviewed in Mills et al., 2007). Indeed, Alu has been established as
the cause of many diseases in human patients, as reviewed in Belancio et al., 2008.
In the next section we will focus on recent studies reporting how REs relate with ageing and
with neurodegenerative diseases. We will focus mostly on REs given their higher abundance in
the human genome.
1.5 Active REs and Disease
1.5.1 REs and ageing
Despite the tight repression that REs are under, there has been accumulating evidence that
REs are capable of mobilizing (i.e., generating de novo insertions) not only in germline cells, but
also in somatic tissues that include brain, liver, and fat (Barbot et al., 2002; Krug et al., 2017; Li
et al., 2013; Muotri et al., 2005; Wood et al., 2016; reviewed in Cardelli, 2018; Dubnau, 2018). In
fact, several studies have reported that this ability to transpose increases with age (Barbot et al.,
2002; Chen et al., 2016; De Cecco et al., 2013a; De Cecco et al., 2013b; Dennis et al., 2012; Hu
et al., 2014; Lee et al., 2012; Li et al., 2013; Maxwell et al., 2011; Patterson et al., 2015; Van Meter
et al., 2014), and that it mainly results from the progressive weakening of the REs repression
mechanisms (Chen et al., 2016; Wood et al., 2016; reviewed in Dubnau, 2018).
The association between ageing and REs derepression (or increased expression) has been
verified in various organisms like budding yeasts (Hu et al., 2014; Maxwell et al., 2011; Patterson
et al., 2015), worms (Dennis et al., 2012), flies (Chen et al., 2016; Li et al., 2013; Wood et al.,
2016), mice (Barbot et al., 2002; De Cecco et al., 2013b; Dupressoir et al., 1995; Lee et al., 2012;
Van Meter et al., 2014), and humans (De Cecco et al., 2013a).
Studies in the chronological ageing model Saccharomyces cerevisiae, revealed not only that
the expression of the yeast RE, Ty1, was increased in older populations of yeast, but also that
reduction of Ty1 expression or repression of its activity would lead to a decrease in age-related
accumulation of genetic damage (or instability) (Maxwell et al., 2011). This association between
ageing and increase in the RE expression was further verified in another yeast model of ageing
(Hu et al., 2014; Patterson et al., 2015).
Similar associations between increased RE expression (or activity) and age have been re-
ported in invertebrates. For instance, while looking for virus-like particles through electron
microscopy in C. elegans, Dennis et al. (2012) showed that the RE, Cer1, is activated with age.
In Drosophila, an RNA deep sequencing approach validated the same trend of increased RE
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expression with age in the fat body (a tissue similar to the mammalian liver and adipose tissue)
and correlated this increase with a concomitant reduction in heterochromatin in old Drosophila
individuals (Chen et al., 2016; Wood et al., 2016). It was also documented that RE expression
correlated with increased DNA damage and decreased lamin-B expression, which was shown to
induce heterochromatin loss and a consequent increase in both RE expression and DNA damage
in young individuals (Chen et al., 2016). Additionally, Wood et al. (2016) were able to show
direct evidence of the increased RE activity, namely, increased de novo insertions with ageing
by using a Gypsy-trap reporter.
In mice, Barbot et al. (2002) and Dupressoir et al. (1995) demonstrated, using northern blot
and reverse transcriptase quantitative PCR (qPCR) approaches, that liver-specific IAP levels
were substantially increased in aged mice. Barbot et al. (2002) further showed that the specific
activation of IAP followed a circadian pattern that was dependent on the activation - through
DNA demethylation - of the gene in which IAP was inserted. The repeated activation of IAP
throughout mice lifespan would lead to a progressive demethylation and increased expression
of IAP in aged mice.
Genome-wide chromatin conformation studies performed in human cells have revealed that
older cells display characteristic heterochromatin alterations when compared to younger cells:
the DNA regions that are normally under a transcriptionally repressive state (gene-poor regions
like intergenic regions, where many REs reside, and centromeres), become less repressed (De
Cecco et al., 2013a). This loosening of heterochromatin in REs (L1 and Alu) sequences results
in the increased expression of those elements, as assayed by RT-qPCR (De Cecco et al., 2013a).
The same authors further corroborated the obtained results by demonstrating that aged mice
present higher levels of both L1 (and other REs) mRNA and genomic copy number in their liver
(De Cecco et al., 2013b).
Since the increase in RE expression with age is widely conserved among such distant taxa,
it has been suggested that RE expression, and RE derepression, is a conserved feature of ageing
(reviewed in Cardelli, 2018; Dubnau, 2018; Maxwell, 2015). However, whether RE derepression
is a cause (contributes for) or a consequence (a by-product) of the age-dependent loss of cellular
function remains unclear.
On the one hand, it is known that the ageing process at the cellular level is accompanied
by an extensive chromatin structure remodeling (reviewed in Cardelli, 2018; Han and Brunet,
2012; López-Otín et al., 2013; Maxwell, 2015; Wood and Helfand, 2013). There is also a
decrease in the activity and e cacy of the posttranscriptional gene regulators, which includes
transcriptional factors and other RNA-based pathways (reviewed in Maxwell, 2015; Wood
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and Helfand, 2013). As mentioned before, RE silencing mechanisms encompass DNA and
histone methylation, which involve chromatin remodeling, and small RNA-based mechanisms.
Furthermore, it is established that environmental stimuli and stress conditions can influence
and trigger RE activity and the respective silencing mechanisms (Cardelli and Marchegiani,
2013; Horváth et al., 2017; Mori et al., 2012). Mori et al. (2012) demonstrated an age-dependent
decrease of Dicer (a protein involved in the small RNA-pathway) expression and miRNAs
production in mice. Interestingly, in vitro experiments also revealed downregulation of Dicer
upon stress conditions (DNA damage and reactive oxidative species). Therefore, it has been
hypothesized that increased RE expression with ageing could be the outcome of the gradual
relaxation and corruption of the RE silencing mechanisms as a result of the age-associated
functional and cellular decline (reviewed in Cardelli, 2018; Maxwell, 2015).
Research involving the longevity regulating protein, SIRT6, L1, and mice revealed not only
an additional role for SIRT6 in silencing L1 activity through the formation of highly transcrip-
tionally repressive heterochromatin in the L1 5’UTR, but also the stress- and age-related gradual
failure of the SIRT6-mediated repression of L1 (Van Meter et al., 2014). SIRT6 is an enzyme
known to promote DNA damage resistance and genomic instability suppression (Mostoslavsky
et al., 2006). Van Meter et al. (2014) observed that SIRT6 was redistributed in response to either
genotoxic stress (which caused DNA damage and genomic instability) and ageing. The redistri-
bution of SIRT6 to other loci would lead to upregulation of L1 activity (Van Meter et al., 2014).
The unconstrained expression of L1 could further compromise the healthy ageing process by
exacerbating the genomic instability and damage present in the ageing cells (Van Meter et al.,
2014; reviewed in Maxwell, 2015).
REs are a known source of DNA damage (Belgnaoui et al., 2006) and, consequently of ge-
nomic instability, inducing toxic e↵ects at a cellular level (Tan et al., 2011; Tarallo et al., 2012;
reviewed in Maxwell, 2015). There are several studies that suggest that REs may contribute to
the ageing process rather than being a consequence of it. Dietary restriction in yeast, worms,
and flies has been reported to significantly increase the healthy lifespan of those animals (re-
viewed in Fontana et al., 2010). However, the mechanisms behind this process are unknown.
Recently, Wood et al. (2016) reported that besides extending the healthy lifespan of flies, dietary
restriction also suspends the age-associated expression of REs and the rate at which these ele-
ments mobilize. These results suggest that RE expression and ageing are strongly related and
maybe intertwined. Moreover, interfering with the production of proteins involved in the small
RNA-based pathway of RE silencing (in somatic tissues), like the PIWI protein AGO2 in flies,
leads to an altered pattern of RE expression and lifespan (Li et al., 2013). Namely, AGO2mutant
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flies revealed a premature desilencing of REs, memory impairment (which was rescued with
the ectopic expression of an AGO2 transgene), and a shortened lifespan (Li et al., 2013). Taken
together the evidence described above is consistent with the hypothesis that RE activation leads
to the age-dependent decline in health (reviewed in Cardelli, 2018; Dubnau, 2018; Fontana
et al., 2010; Maxwell, 2015).
Interestingly, it has been established that in what concerns retrotransposition events in
somatic tissues, brain is the tissue where RE mobilization occurs with the highest frequency
(Baillie et al., 2011; Coufal et al., 2009; reviewed in Solyom and Kazazian, 2012). Indeed,
unconstrained RE activity has been hypothesized to contribute to the development of brain
disorders, such as schizophrenia and Rett syndrome (Bundo et al., 2014; Gu↵anti et al., 2016;
Muotri et al., 2010). In the following section, we explore more deeply the link between RE
derepression and the development of neurodegenerative diseases.
1.5.2 REs and neurodegeneration
REs and their unrestricted activity have been associated with neuronal decline and many
ageing-related diseases, namely neurodegenerative diseases. Indeed, the nervous system seems
to be a hotspot for RE derepression, as suggested by several reports associating several neu-
rodegenerative disorders with derepressed REs like LTR, SINEs (Alu and Alu-like), and LINEs
(L1 and LINE-like) (Table 1.1) (Li et al., 2013; reviewed in Dubnau, 2018; Thomas et al., 2012).
However, whether or not RE derepression is a cause or consequence of the neuronal dysfunction
remains unclear.
Besides the direct mutagenic role associated with TEs mobilization, TEs may also trigger
strong neuroinflammatory responses that worsen the pathogenicity of the diseases (reviewed in
Kassiotis and Stoye, 2016). Indeed, the accumulation of Alu RNAs has been shown to provoke
an immune response that leads to the degeneration of the retinal pigmented epithelium in
age-related macular degeneration, which consequently leads to blindness (Tarallo et al., 2012).
Interestingly, knockdown of DICER1, a miRNA-processing enzyme, induces accumulation of
Alu and Alu-like SINEs and degeneration of human and mouse retinal epithelium, respectively
(Kaneko et al., 2011). Subsequent studies performed by Tarallo et al., 2012 revealed that in the
absence of DICER1, Alu transcripts are not cleaved and degraded. Therefore, the Alu transcripts
accumulate in the cell and activate the NLRP3 inflammasome, thereby inducing a toxic response
that culminates with cell apoptosis.
The involvement of REs in neurodegeneration is further corroborated by several evidence
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Table 1.1: Evidence of association between neurodegenerative diseases and TEs.
Disease Transposable elements Disease genes Models References
Age-related Macular Degeneration Accumulation of AlumRNAs induce an immune response that leads to inflamation and cell apoptosis. DICER1 human, mice Kaneko et al., 2011; Tarallo
et al., 2012
Aicardi-Goutiéres syndrome (AGS) ADAR1 primarily edits Alus in RNA Pol II transcribed mRNAs, ADAR1 knockout neuronal progenitor
cells exihibit spontaneous interferon production, inhibition of mRNA translation, and apoptosis; L1
activity is upregulated in several models with AGS-related mutations.
ADAR1 (1q),
SAMHD1,
TREX1, IFIH1
human, mice Chung et al., 2018; Zhao et
al., 2013
Alzheimer’s disease Increased activation of L1 and human endogenous retroviruses (HERVs)s in 638 human brains from
Alzheimer patients; Expression of the human Tau gene in the fly brain resulted in the global activation
of TEs and its associated genomic instability.
MAPT, APP,
PSEN1 (14q),
human, flies Guennec et al., 2017; Guo et
al., 2018
1 patient with Alu-mediated PSEN1 exon 9-10 deletion. PSEN2
Amyotrophic Lateral Sclerosis - Frontotempo-
ral dementia (ALS-FTD)
Increased expression of HERVs and LINEs resulted in neurotoxic e↵ect and led to motor neurodegen-
eration in mice.
C9ORF72 (9p) human, mice Li et al., 2012; Prudencio et
al., 2017
Sporadic Amyotrophic Lateral Sclerosis (ALS) Increased expression of HERVs (and other REs) in brain tissues of ALS patients; forced expression of
TDP-43 in the fly brain resulted in activation of gypsy (and other REs), thus resulting in the neurode-
generative phenotype in the flies.
TDP-43 human, mice,
flies
Douville et al., 2011; Krug
et al., 2017; Li et al., 2015
Amyotrophic Lateral Sclerosis type 12 5 patients with di↵erent types of Alu-mediated OPTN exon deletions. OPTN (10p) human Iida et al., 2012; Maruyama
et al., 2010
Ataxia telangiectasia Alu-mediated exonization in ATM intron 20; increased genomic L1 copy number in hippocampi from
ataxia telangiectasia patients.
ATM (11q) human, mice Coufal et al., 2011; Pagani et
al., 2002
Epilepsy 5 patients with Alu-mediated rearrangement of portions of ALDH7A1 ; 3 patients with Alu-mediated
CDKL5 deletions of various sizes.
ALDH7A1 (5q),
CDKL5 (Xp)
human \cite{Me↵ord2015,
Erez2009}
Fragile X-associated tremor ataxia syndrome
(FXTAS)
Excess rCGG repeats induce the activation of gypsy in flies. Knockdown of gypsy in flies with FXTAS
rescued the WT phenotype.
FMR1 flies Tan et al., 2011
Friedreich ataxia Expanded GAA triplet repeat in central Alu linker located in FXN intron 1 with allelic suppression. FXN (9q) human Clark et al., 2004
Parkinson’s disease 1 patient with Alu-mediated PARK2 exon 10 deletion; 1 patient with Alu-mediated DJ1 exon 1-5
deletion.
PARK2 (6q), human, mice Bonifati et al., 2003;
L1 inhibition in mice under oxidative stress partially prevent the neurodegenerative phenotype. DJ1 (1p) Morais et al., 2016; The et
al., 2017
L1 inhibition in mice under oxidative stress partially prevent the neurodegenerative phenotype.
Rett Syndrome• Increased rates of L1 retrotransposition in mouse models and human patients. MeCP2 human, mice Muotri et al., 2009
Schizophrenia Increased genomic L1 copy number in the prefrontal cortex of patients, iPSCs with 22q11 deletion,
and mouse and macaque models.
human, mice,
macaque
Bundo et al., 2014
Multiple Sclerosis (MS) Association of HERVs in brain tissue of MS patients. human Morandi et al., 2017
• Rett Syndrome is considered a neurodegenerative disorder and not a neurodegenerative disease. This table was adapted from Krestel and Meier, 2018
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regarding human LTR retrotransposons, namely HERV (Table 1.1) (Douville et al., 2011; Li et al.,
2012; Li et al., 2015; Morandi et al., 2017; Prudencio et al., 2017). HERV expression has been
associated with multiple sclerosis, a chronic demyelinating disease of the CNS that ultimately
leads do neurodegeneration and other progressive neurodegenerative diseases like amyotrophic
lateral sclerosis (AML) and frontotemporal lobar degeneration (FTLD) (Douville et al., 2011;
Li et al., 2012; Li et al., 2015; Prudencio et al., 2017; reviewed in Morandi et al., 2017). Recent
evidence from meta-analysis and polymerase chain reaction (PCR)-based studies revealed that
TDP-43 protein interacts and binds to the LTR sequences of REs (Li et al., 2012; Li et al., 2015).
TDP-43 protein is commonly found in cytoplasmic inclusions of individuals with both AML
and FTLD (reviewed in Waddell et al., 2014). The involvement of REs was further corroborated
by a recent study in which the human TDP-43 gene was introduced in Drosophila genome (Krug
et al., 2017). Forced expression of TDP-43 inDrosophila neurons and glia induced RE expression
and recapitulated several neurodegenerative characteristics seen in human AML patients (Krug
et al., 2017). Genetic repression of gypsy, one of the REs induced by forced TDP-43 expression,
resulted in a reduced neurotoxic e↵ect, suggesting that REs contribute to TDP-43-mediated
toxicity. The pharmacological inhibition of retrotransposition also led to the same phenotype.
In the same study, Krug et al. (2017) revealed that TDP-43 expression in Drosophila triggers
the expression of gypsy by disrupting siRNA-mediated silencing of REs. This derepression
ultimately leads to the DNA damage-mediated programmed cell death. Higher expression of
REs was also found in post mortem brains of FTLD patients (Li et al., 2012; Prudencio et al.,
2017).
Studies in mouse models of Parkinson’s disease reported that induction of acute oxidative
stress in post-mitotic nerve cells instigates L1 expression, the formation of DNA DSBs, and cell
death (The et al., 2017). By using either the reverse transcriptase inhibitor, stavudine, or a siRNA
against ORF2 in animals under oxidative stress, The et al. (2017) were able to partially prevent
the neurodegenerative phenotype. Together, these findings suggest that L1 overexpression has
a role in the stress-induced neuronal death.
All these studies corroborate a direct and active role of REs in the neuronal function decline
seen in several neurodegenerative diseases. However, none of the studies performed until now
was able to clearly determine whether RE expression (and activity) is a cause or a consequence
of the neurodegenerative toxicity. Nevertheless, research on neurodegenerative diseases related
with TDP-43 proteins seems to support the idea that REs are behind the development of sporadic
forms of such diseases (Krug et al., 2017).
Furthermore, research performed in mice also suggest that L1-mediated genomic instability
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might trigger cell death in age-related diseases, namely diseases involving neurodegeneration,
since the reduction of L1 expression resulted in a neuroprotective e↵ect (The et al., 2017). How-
ever, although these two studies show a causal e↵ect of REs on neurodegeneration, the results
are based on RNA interference (RNAi) against gypsy or anti-reverse transcriptase activity drug
experiments. Both these approaches have side-e↵ects which have not been ruled out in such
studies. For instance, gypsy RNAi might be a↵ecting expression of normal genes that happen to
have gypsy-related sequences within, whereas the anti-reverse transcriptase drug could be af-
fecting the telomere physiology (which also depends on reverse transcriptase activity), amongst
others. Establishing the causal role between REs and neurodegeneration is important because
RE derepression could represent a therapeutic target to prevent or mitigate the age-related
neuronal decline. The development of drugs or therapeutics that would specifically avoid RE
derepression or RE activity would help prolong the productive life of neurons, thereby promot-
ing healthy ageing.
The purpose of this dissertation was to directly test whether RE activity could be a cause
of neuronal function decline and degeneration. Based on the literature described above, we
assume a model where, as the organism ages, the surveillance mechanisms of REs tend to be
weakened, thereby unleashing REs (Figure 1.4). Once expressed, REs are able to undergo de novo
transposition events, thus generating genomic instability and DNA damage. The accumulation
of such insults may trigger either inflammatory processes or programmed cell death, both
leading to neurodegeneration. We therefore hypothesize that direct expression of a RE in
the neurons of a living animal throughout its lifespan, in conditions where the expression
and activity of the RE are naïve to the host RE surveillance system (i.e., the RE is immune to
transcriptional and post-transcriptional repressive systems), will lead to progressive loss of
neuronal function.
To directly test our hypothesis we have forced the expression of a human RE, L1, in the fly
(D. melanogaster) CNS and assayed for neuronal function in ageing animals by performing a
behavioral assay (negative geotaxis assay) 2, 20, and 40 days after eclosion. The results were
negative for both of the tested lines, thus suggesting - a priori - that RE expression does not
influence neurodegeneration (seen with age). We then carried out several in vitro and in vivo
experiments to determine if the human L1 was able to retrotranpose as expected in Drosophila.
We conclude that we should take the result with caution that RE expression does not induce
an age-dependent loss in neuronal function, as we have not yet been able to provide definitive
evidence that human L1 retrotransposes e ciently in the fly nervous system. We speculate that
L1 might require additional specific human factors (that are absent in flies) to retrotranspose.
25
CHAPTER 1. INTRODUCTION
Neurodegeneration
Ageing
RE RE
?
Figure 1.4: Hypothesis: RE expression in neurons contributes to the neuronal function de-
cline and degeneration associated with age. As the organism ages, RE expression, which is
normally silenced by the host cells, tends to increase. Once expressed, REs (like the human
L1), start insulting the stability of the genome by trying to retrotranspose. The accumulation
of DNA damage and genome instability over time leads to the gradual functional and cellular
deterioration of neurons (neurodegeneration) which can culminate in the development of a
neurodegenerative disease.
1.6 Rationale
1.6.1 D. melanogaster as the ideal model
The invertebrate model Drosophila melanogaster has been used in research for the last hun-
dred years. Since then, a lot has been discovered in Drosophila and extrapolated to other model
organisms. Drosophila and humans share many basic biological, physiological, and neurological
properties. The overall homology between fly and mammal nucleotides is 40 %, and about 75 %
of the genes related to human diseases are known to have functional orthologs in the fly (Fortini
et al., 2000; Pandey and Nichols, 2011; Reiter et al., 2001; Rubin et al., 2000). In fact, several
human diseases have been successfully recapitulated in flies through transgenic expression of
the human genes associated with those diseases, like the amyotrophic lateral sclerosis- and
frontotemporal lobar degeneration-associated gene TDP-43 (Krug et al., 2017).
Drosophila is a valuable model to study human neurological diseases and neurodegeneration
(reviewed in Lloyd and Taylor, 2010). For instance, the NTE gene which is nowadays known to
be important in neuronal development for the maintenance of stability of the membranes that
surround neurons, in particular of the axons, was initially discovered in a screen performed in
Drosophila (Akassoglou et al., 2004; Heisenberg and Böhl, 1979; Rainier et al., 2008; reviewed in
Lessing and Bonini, 2009). Alzheimer’s, Parkinson’s, and Huntington’s disease are some of the
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diseases that have been studied in the fly model (Lessing and Bonini, 2009; Lloyd and Taylor,
2010; Pandey and Nichols, 2011).
Large Drosophila populations can be rapidly generated, as their maintenance is relatively
simple and cheap, and their life cycle is small and fast-paced (~10 days at 25 ºC). The use of
insect species, like D. melanogaster, is ethically recommended as part of an initiative to reduce,
replace, and refine research performed in large, warm-blooded experimental animals, such as
mice and chimpanzees. There are several genetic tools available in Drosophila that allow to
manipulate and edit the fly genome in a temporal and spatial manner (reviewed in Piper and
Partridge, 2018).
Flies have a relatively short lifespan of about two-three months (reviewed in Sun et al.,
2013). Nevertheless, flies show clear symptoms of ageing as soon as one month after eclosion
(Figure 1.5). Symptoms of ageing (otherwise considered as ageing-associated markers of loss
of function) in the fly include reduced feeding, decreased reproductive capacity (decreased
egg production, laying, and hatching), and decline in neuronal function, which encompasses
impaired learning, memory, and debilitated negative geotaxis response (reviewed in He and
Jasper, 2014; Piper and Partridge, 2018).
Time (days after eclosion)
Ageing-related functional decline Indicators of degeneration
heart “failure”
gut dysplasia & leakiness
standing still & lying supine
memory
immunocompetence
egg production (Fertility)
resistance to toxic compounds
mobillity/activity (negative geotaxis, walking, flying)
heterochromatin maintenance
resistance to starvation
basal metabolism
0 60
Figure 1.5: Flies show physiological signs of ageing. Adapted from Piper and Partridge, 2018.
Several tools have been developed for and utilized in Drosophila to determine the influence
of particular genes in a specific subset of cells or tissue in ageing (and lifespan) (reviewed in He
and Jasper, 2014). There are diverse genetic approaches to generate mutations and manipulate
expression, which account for insertion mutagenesis mediated by P-element, gene expression
alterations by GAL4-upstream activating sequence (UAS) system (described in more detail below),
and RNAi-mediated knockdown of genes (reviewed in Sun et al., 2013).
Physiological, biochemical, and behavioral assays are normally carried out to verify if the
mutated or manipulated gene influences ageing (or neurodegeneration) (Sun et al., 2013). In
this work we will focus on the assays utilized to study neurodegeneration and ageing in flies.
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For instance, Li et al. (2013) resorted to a well-established learning and memory assay to study
the correlation between age-dependent neurofunctional decline and activation of TEs (Li et
al., 2013). One of the most simple assays used to study neurodegeneration (and ageing) in
flies is the mean and maximum lifespan measurement, which consists in counting the number
of dead flies throughout time (reviewed in He and Jasper, 2014; Lessing and Bonini, 2009;
Sun et al., 2013). However, maximum lifespan is a demographic assay and does not provide
details on age-related neuronal dysfunctions. Therefore, there are additional strategies to
study those changes that range from more classic approaches, like histology, to biochemical
and functional methods, like quantification of protein aggregation and characterization of
fly locomotor behavior, respectively (reviewed in He and Jasper, 2014; Lessing and Bonini,
2009). Locomotor activity is one of the parameters used to study health span (Sun et al., 2013).
The negative geotaxis assay (also known as climbing assay) is a quantitative and non-invasive
approach tomeasure the locomotor decline associatedwith ageing (due tomuscle and respective
innervation function alteration) and neurodegeneration. The assay is based on the natural
negative geotactic behavior of flies, especially when startled. Once tapped to the bottom of a
tube, WT flies tend to climb upwards quickly. This climbing ability is lost progressively as the
animals age, and is translated into failed attempts to climb and falling to the bottom of the
tube (reviewed in He and Jasper, 2014; Sun et al., 2013). Advantages of the negative geotaxis
assay in studying neuronal function decline include the robustness of the behavior, the large
amount of individuals that can be tested simultaneously, and the fact that it enables to assess
for a common feature inherent to human neurodegenerative disorders, which is ataxia (Lessing
and Bonini, 2009). Another major advantage of this assay is the simplicity of the set up, thereby
making it very a↵ordable.
The genome of D. melanogaster is one of the best studied and annotated genomes among
eukaryotes. Although flies have several active LINE-like elements, they lack a true homolog
of the mammalian L1 and SINEs (Kramerov and Vassetzky, 2011; Perrat et al., 2013; reviewed
in Kapitonov et al., 2009). Therefore, introducing a human L1 or Alu in the fly genome would
permit studying the role of RE derepression in the ageing-associated neurofunctional decline
without interference of the repression mechanisms, since the mechanisms would not recognize
the extraneous REs. Hence, we would be able to study the L1 activity and its consequences
directly, which is crucial to determine a causal relationship. A previous study, in which both
human and mouse L1 were introduced in chicken cells, demonstrated that L1 was able to
mediate retrotransposition events in a new host (chickens lack an endogenous source of L1),
suggesting that L1 does not require additional factors to mobilize in the genome (Suzuki et al.,
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2009; Wallace et al., 2008a). Having this in mind, we hypothesized that the system would work
in the flies as well. The system used is described in the following section (Section 1.6.2).
1.6.2 Strategy
To directly investigate if RE derepression causes the neuronal function decline associated
with age, we have established an unique heterologous system that allows tissue specific expres-
sion of the human L1 in flies (Figure 1.6). More specifically, we have resorted to the binary
system GAL4-UAS to control the expression of L1 temporally and spatially. The GAL4-UAS
system is a powerful genetic tool developed in Drosophila in 1993 to restrict the expression of a
gene of interest to specific tissues (Brand and Perrimon, 1993; Poirier and Seroude, 2005). In
flies, the GAL4-UAS expression system comprises two principal components, which are usually
separated into two di↵erent transgenic flies: the yeast GAL4 transcriptional factor and the gene
of interest under the regulatory control of a UAS promoter. In a transgenic line, a native tissue-
specific promoter (also known as driver) drives the expression of GAL4, which cannot activate
anything because there is no UAS present. On the other hand, the other transgenic line has a
UAS promoter regulating the expression of an e↵ector gene (the gene of interest), which is silent
given the absence of GAL4. Only when these two transgenes are placed in the same fly, there
will be expression of the e↵ector gene in a tissue-specific manner. Thus, by crossing these two
transgenic lines, the o↵spring will have both transgenes in every cell. However, only the cells
in which the driver is "ON" will have the e↵ector gene being expressed (Brand and Perrimon,
1993). Hence, we can restrict the expression of L1 to the CNS by crossing a fly line containing
GAL4 under the regulatory control of a pan-neuronal driver, like elav, nSyb, or GMR57C10with
a transgenic line carrying a UAS sequence regulating a human L1 (Wagsta↵ et al., 2011).
UAS L1Driver GAL4
Retrotranspositionà Neuronal decline?
Figure 1.6: Schematic illustration of the human LINE system. A "Driver"(yellow rectangle),
for instance, aDrosophila pan-neuronal promoter, regulates the expression of the transcriptional
activator, GAL4 (blue rectangle). Once expressed, the GAL4 protein (blue diamond) binds to
the UAS sequence (pink rectangle) in trans and activates the expression of the e↵ector gene, L1
(orange rectangle). L1 proteins (ORF1p and ORF2p, orange circle) are produced and mediate
retrotransposition, which, according to our hypothesis, would lead to the neuron functional
decline associated with age.
To demonstrate that the human L1 is functionally retrotransposing in Drosophila, we have
engineered a SINE reporter element (Figure 2.3) using a similar strategy as Belgnaoui et al.
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(2006). The cellular readout chosen for this system is the production of sfGFP. The Alu reporter
element comprises the synthetic human AluYb8 (hereafter, Alu) with a GFP reporter cassette
placed towards Alu 3’UTR in the antisense orientation (SINE[Act-sfGFP]) (Dewannieux et al.,
2003; Wallace et al., 1991). The GFP cassette consists of a constitutive Drosophila Actin5c-
promoter (Act5c) regulating a de novo-synthetized sfGFP, an inverted intron (intron 16) of the
Drosophila Mhc gene, MhcInt16, placed in the same orientation as Alu (disrupting the sfGFP
sequence), and a SV40 PolyA terminator sequence (Pfei↵er et al., 2010; Qin et al., 2010). To
ensure the expression of Alu and the splicing of the intron, Alu was placed under the regulatory
control of a Drosophila alpha-Tubulin at 84B (Tubulin, Tub) promoter, Tub-SINE[Act-sfGFP]. In
this system, to produce sfGFP, Alumust be transcribed, post-transcriptionally processed, and
retrotransposed into the genome in trans by L1 proteins. The splicing of the intron is crucial to
remove the intron and enable the production of a functional sfGFP after retrotransposition of
the spliced transcript into the genome. The amount of retrotransposition can be quantified by
direct inspection of the adult CNS following UAS-L1 expression in the CNS using a neuronal
driver such as elav-Gal4 in the presence of the SINE[Act-sfGFP] construct. Although the Alu
reporter element increases the complexity of our system, it also provides an easier and faster
mode of detecting retrotransposition events due to its shorter size and rapid retrotransposition
capacity (Kroutter et al., 2009; reviewed in Deininger, 2011).
1.7 Aims
This dissertation proposes to determine if RE expression causes neuronal degeneration
and/or neurofunctional decline associated with age. Additionally, we will seek for evidence
that human L1 can retrotranspose in Drosophila cells. To achieve these objectives, we will:
• Generate L1 and Alu transgenic lines;
• Analyse the expression of L1 in the transgenic lines;
• Characterize the locomotor ability of flies expressing L1 in the nervous system;
• Characterize the production of functional L1 ORF2p in the context of a full-length L1 in
vivo and in vitro;
• Test the L1/Alu system in vitro and in vivo;
• Characterize the production of functional L1 ORF2p from a shorter version of L1 in vitro;
• Characterize the L1 ORF2/Alu system in vitro.
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Materials and Methods
2.1 Drosophila melanogaster: fly lines and crosses
All the stocks and crosses were maintained at 25 ºC under a controlled atmosphere with
70 % humidity on cornmeal-agar medium. Mutant or transgenic fly stocks used in these studies
are described on Table 2.1, as well as their source. The UAS-L1 and the Tub-Alu[Act-sfGFP]
transgenic lines were generated via P element insertion (Rubin and Spradling, 1982). Briefly,
plasmids containing those constructs flanked by the ends of the P element (3’ P and 5’ P) were
co-injected with a plasmid carrying the P element gene into w[1118] embryos. Existing fly stock
lines were used to generate new stocks through genetic crossing.
2.2 Startle-induced Negative Geotaxis Assay
The startle-induced negative geotaxis assay, also known as climbing assay, is a broadly used
assay to study locomotor capacity and its age-dependent decline (Ganetzky and Flanagan, 1978).
This assay exploits the negative geotaxis response that flies exhibit after being startled (Figure
2.1). After being tapped to the bottom of the tube, WT flies rapidly climb up the vial. As flies
age, this ability is gradually lost and older flies are no longer able to climb to the top of the vial.
The assay was performed as previously described (Barone and Bohmann, 2013). Flies were
collected between 0–24 hours (h) after eclosion. The flies were transferred into new food twice
a week. Before the assay, flies were submitted to two acclimatization periods. Firstly, groups of
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Table 2.1: List of the D. melanogaster stocks used in the experiments.
Category Short name (ID) Genotype Origin
Control w[1118] w[1118]; ; ; Bloomington Stock Center 3605
drivers-GAL4 57C10> w[1118]; P{y[+t7.7] w[+mC]=GMR57C10-GAL4}attP2 Bloomington Stock Center 39171
drivers-GAL4 arm> ; armGAL4; Pedro Domingos’ lab (ITQB)
drivers-GAL4 pBDP> w[1118]; P{y[+t7.7] w[+mC]=GAL4.1Uw}attP2 Carlos Ribeiro’s lab (CCU)
drivers-GAL4 elav> elav-GAL4; ; Christen Mirth’s lab (IGC)
drivers-GAL4 nSyb> ; ; nSyb-GAL4; Rita Teodoro’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Alua> ; If/CyO; Alu_M31-F1; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Alub ; If/CyO ; Alu_F25-M1; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Aluc : Alu_F21-M5; MKRS/TM6B Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Alud ; Alu_M51-F1 /CyO; MKRS/TM6B; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Alue ; Alu_F35-M1 /CyO; MKRS/TM6B; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Aluf ; Alu_F34-M1 /CyO; MKRS/TM6B; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Alug ; If/CyO; Alu_M53-M1/TM6B; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Aluh Alu_F21-M3-F1; If/CyO ; MKRS/TM6B; Alisson Gontijo’s lab (CEDOC)
Tub-Alu[Act-sfGFP] Alui Alu_F32_M1/FM7c; +/bal; +/bal; Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1a ; L1_M68-F1; ; Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1a_bal ; L1_M68-F1 ;MKRS/TM6B; Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1b ; If/CyO ; MKRS/TM6B; L1_F1_F4 Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1c ; ; L1_F1_M3; Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1d ; ; L1_F1_F2 ; Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1e ; ; L1_M16_M2/TM6B Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1f ; ; MKRS/TM6B; L1_M3_F1 Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1g ; ; L1_M13_F1; Alisson Gontijo’s lab (CEDOC)
UAS-L1 L1h ; L1_M68_F1; elavG5-G4; Alisson Gontijo’s lab (CEDOC)
UAS-L1; Tub-Alu[Act-sfGFP] L1a+Alub ; L1_M68-F1; Alu-F25; Alisson Gontijo’s lab (CEDOC)
5 to 20 male flies were placed at RT for 5 minutes (min). Secondly, the flies were transferred
to empty climbing vials where they were allowed to adapt for 5 min (Figure 2.1, 1-2). Then,
the assays started with the tapping of the flies to the bottom of the vial (Figure 2.1, 3). Fly
behavior was recorded for 15 seconds (s). Each assay comprised five tappings with 1 min
intervals inbetween. The percentage of flies climbing above 2, 4, and 6 cm, 5 and 10 s after
initiation of the assay was scored (Figure 2.1., 4-5). As demonstrated in Appendix A Figure A.1,
flies locomotor ability tends to decrease with age regardless of the condition scored. Since the
decrease in the locomotor ability was best described in the conditions C (above 4 cm, after 5 s)
and D (above 6 cm, after 5 s), the percentage of males above 6 cm after 5 s for each assay was
plotted using box plots. Between 56 and 254 flies of each genotype were assayed 2, 20, and 40
days after eclosion at the same period of the day, at RT, and under the same light conditions.
Each genotype was tested between 5 and 24 times.
Two independent assays were performed with two di↵erent UAS-L1 (hereafter, >L1) trans-
genic lines (>L1a and >L1e) (Table 2.1). In the first experiment, test animals were obtained from
the cross between >L1a and the pan-neuronal GAL4 driver lines, GMR57C10, nSyb and elav
(hereafter, 57C10>, nSyb>, and elav>, respectively). To control for background and transgene
insertion e↵ects, animals from several control genotypes were assayed. These included flies re-
sulting from crosses between the GAL4 driver lines and the background control stock, w[1118]
(nSyb>, elav> and 57C10>), between the control driver line, pBDP-GAL4 (hereafter, pBDP>)
and the >L1a line (pBDP>L1a), and between the >L1a and w[1118] (>L1a). pBDP> carries an
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Figure 2.1: Representative scheme of the negative geotaxis assay procedure. Flow diagram
illustrating the negative geotaxis assay used to monitor the age-dependent locomotor behaviour
in flies. After tapping a test tube containing groups of 5-20 male flies, their anti-gravitational
response was recorded and posteriorly analysed (1-5). The anti-gravitational response of flies
with increasing ages was scored as the percentage of males that climbed above 6 cm, 5 s after
initiating the assay.
"empty" GAL4 driver, identical to the 57C10> line (i.e., has the same genetic background), but
without the neuronal enhancer. In the second experiment, test animals were obtained from the
crosses between >L1e and 57C10 >, w[1118], and pBDP> (57C10>L1e, >L1e, and pBDP>L1e,
respectively). The cross between 57C10> and w[1118] animals was included as a GAL4 driver
control.
2.3 Plasmids
To assemble a pUASTN-LINE1 (hereafter referred to as pUAS-L1), the plasmid pBS-L1PA1-
CH-mneo (Addgene plasmid # 51288; gift from Astrid Roy-Enge) was digested with NheI and
EcoRI enzymes (Wagsta↵ et al., 2011). The resulting L1_ORF1_ORF2 fragment was inserted
into a pUASTN previously co-digested with both NheI and EcoRI (Figure 2.2). pUASTN was
made by introducing new restriction sites by annealed oligo cloning in the original pUAST
(Brand and Perrimon, 1993). Briefly, pUAST was opened with EcoRI and BglII, and posteriorly
ligated to overhangs resulting from the annealing of two primers. This cloning resulted in the
conversion of the original EcoRI-BglII fragment into NheI-AgeI-EcoRI, generating the pUASTN
plasmid (Figure 2.2). This work was done by Fabiana Heredia and André Macedo.
To generate the SINE retrotransposition reporter element (pTub-Alu[Act-sfGFP]), a human
AluYb8 sequence containing a docking site with specific restriction enzyme sites, NcoI and AgeI,
towards its 3’ end was used (Figure 2.3). To assemble the GFP reporter cassette, a Drosophila
Actin5c-promoter (Act5c) sequence was amplified and new AgeI restriction sites were intro-
duced in both extremities of the sequence through PCR. The resulting Act5c PCR product
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Figure 2.2: Cloning scheme for the construction of pUASTN-L1. The pUAST plasmid was
modified by introducing NheI, AgeI, and EcoRI restriction sites through primer annealing and
ligation to a previously BglII and EcoRI digested pUAST. L1was obtained from aNheI and EcoRI
digestion of pBS-L1PA1-CH-mneo (Addgene # 51288). Only the restriction enzymes used in the
procedure are shown. The fragments in the scheme are out of scale.
was digested with AgeI and inserted into a plasmid containing a de novo-synthetized sfGFP
sequence disrupted by theMhcInt16 intron, that had been previously opened with AgeI. XhoI
and NcoI restriction sites were introduced into the 5’ and 3’ extremities of the SV40 PolyA
terminator sequence via PCR amplification. The resulting PCR product was then co-digested
with both XhoI and NcoI, and ligated to the Act5c-AgeI-sfGFP plasmid previously co-digested
with the same enzymes (XhoI and NcoI), thus generating the Alu[Act-sfGFP] reporter cassette.
To guarantee production of the Alu[Act-sfGFP] reporter element and splicing of theMhcInt16,
a constitutive Drosophila alpha-Tubulin at 84B (Tubulin, Tub) promoter was placed before the
element using the KpnI and XhoI restriction sites, as depicted in Figure 2.3. The Tub promoter
was obtained from a pCaSpeR4 backbone (JB25 plasmid, gift from J Bischof, from the Basler lab
(UZH, Switzerland)). This work was done by Fabiana Heredia and André Macedo.
The pUASTN-L1_ORF2 (hereafter referred to as pUAS-ORF2) plasmid was generated by
cloning an AgeI-EcoRI digested L1_ORF2 (present in pBS-L1PA1-CH-mneo) fragment into the
previously AgeI-EcoRI digested pUASTN vector (Figure 2.4).
To confirm the sequence of the final plasmids, a reaction of 100 ng/µL of plasmid DNA
with 10 pmol/µL of primer was subjected to Sanger sequencing (STABVIDA Sanger sequencing
service). Since Sanger sequencing provides low quality sequences at the beginning and at the
end of the sequence, two di↵erent primers flanking each side of the inserts were chosen for
each plasmid, thus assuring high-quality sequencing for the constructs through comparison.
Table A.1 in Appendix A lists the plasmids used in this dissertation.
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Figure 2.3: Cloning strategy for the construction of the pTub-SINE[Act-sfGFP]. 1. A
Drosophila Actin5c promoter (orange) and a SV40 polyA terminator (blue) sequence were am-
plified through PCR, digested with AgeI and co-digested with XhoI and NcoI, respectively. The
resulting fragments were cloned into a plasmid containing a de novo synthetized sfGFP (green)
with a disruptingMhcInt16 (red), producing a GFP reporter cassette. 2. The cassette was intro-
duced into a plasmid containing the human Alu sequence (yellow) in the opposite direction by
co-digestion with AgeI and NcoI, producing the Alu[Act-sfGFP]. 3. The Alu[Act5c-sfGFP] was
cloned into a plasmid containing a Drosophila tubulin promoter (Tub, light purple) via KpnI
and NotI co-digestion. 4. Representation of the final plasmid, pTub-Alu[Act-sfGFP]. Only the
restriction enzymes used in the procedure are shown.
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Figure 2.4: Cloning scheme for the construction of pUAS-ORF2. pUASTN was digested with
AgeI and EcoRI to open and ligate with a previously AgeI and EcoRI digested ORF2 fragment
(from pBS-L1PA1-CH-mneo (Addgene # 51288)). Only the restriction enzymes used in the
procedure are shown. The fragments in the scheme are out of scale.
35
CHAPTER 2. MATERIALS AND METHODS
2.4 Polymerase Chain Reaction (PCR)
PCR was used together with gel electrophoresis to perform colony, digestions, and transfec-
tions screenings.
Bio-Rad’s T100TM Thermal Cycler and NZYtech’s Supreme NZYTaq 2x Green Master Mix
were used for standard PCR reactions. For this purpose, the manufacturer’s instructions were
followed. The PCR cycle parameters and the primers used are depicted in Table 2.2 and 2.3,
respectively.
Table 2.2: List of the PCR and RT-qPCR programs followed in the experiments.
Cycle
Initial denaturation Denaturation Step Annealing Step Elongation/Extension Step Final extension
Temperature (ºC) 95 95 60 72 72
PCR (35 cycles) Time 60 s 30 s 30 s 60 s / kb 5 min
qPCR (45 cyles) Time 10 min 10 s 10 s 10 s
Table 2.3: List of primers used in PCR and RT-qPCR experiments.
Technique Target Primer Sequence (5’ - 3’) Expected Band Size (bp)
PCR, Line-1 ORF2 L1orf2-F CACTGCTGGTGGGACTGCAA 167
RT-qPCR; L1orf2-R AACATCCGGGTGCAGGTGTC
PCR, sfGFPcassette with intron SuperfolderGFP_F CCTATGGCGTGCAATGCTTC 467
RT-qPCR; SuperfolderGFP_R CAGCACCATATGATCCCGCT
PCR; sfGFPcassette without intron SuperfolderGFP_F CCTATGGCGTGCAATGCTTC 239
sfGFP_no_MHCintron_1_R ATTATATTCGAGCTTGTGGC
RT-qPCR; rp49 NewRP49_p6_F TTGAGAACGCAGGCGACCGT 96
NewRP49_p6_R CGTCTCCTCCAAGAAGCGCAAG
2.5 Gel electrophoresis and purification
Agarose gel electrophoreses were used as a read-out for PCR products, digestion of plas-
mids (with restriction enzymes) and DNA quality control (e.g., to monitor plasmid integrity).
Between 0.7-2.0 % (w/v) agarose powder (NZYtech) was mixed with Tris-acetate-EDTA (TAE)
1X (NZYtech) and further stained with 0.004 % (v/v) GreenSafe Premium (NZYtech) to allow
DNA visualization. Since agarose concentration determines the distance between DNA bands
of a given length, the choice of which concentration and percentage of agarose to use depended
on the expected fragment sizes. Hence, digestion products with smaller sizes (~0.2 kb) were
resolved on 2 % agarose gels, whereas 0.7 % agarose gels were used for both separation of
5-10 kb DNA fragments as suggested by Burland et al. (1996) and Voytas (2001), and for DNA
quality verification. Amplicons were usually resolved in either 1.2 % or 0.7 % agarose gels,
according to the expected size. Additionally, the molecular marker NZYDNA Ladder III and 6x
NZYDNA loading dye (NZYtech) were used to recognize the approximate molecular weight of
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the DNA after migration and to prepare DNA samples for loading. ChemiDocTM XRS (Bio-Rad
Laboratories) and its system were used for gel imaging.
Almost every cloning strategy required DNA purification of either amplicons or digested
fragments from agarose gels following electrophoresis. For this purpose, the desired bands were
cut and purified with NZYGelpure (NZYtech), following the instructions of the manufacturer.
DNA concentrations and quality were measured using NanodropTM 2000 Spectrophotometer
(Thermo Scientific). The samples would then be either used for cloning or stored at -20 ºC.
2.6 DNA ligation, competent cell transformation and plasmid DNA
isolation
DNA insert ligation into vector DNA was performed by following the T4 DNA ligase proto-
col from ThermoFisher Scientific. Briefly, we joined 50-100 ng of vector and insert in a molar
ratio of 1:3 (vector to insert). In order to calculate the exact amount of insert DNA to add, we
resorted to Equation 2.1. Both the vector and the insert were heated at 65 ºC for 5 min before
being added to the ligation mixture. After mixing, the reaction was incubated at RT for 3-4 h
and then shifted into 4 ºC ON. For every ligation, a negative control (without insert) was also
made.
Vector amount (ng) ⇥ Insert size (kb)
Vector size (kb)
⇥ Molar ratio insert
vector
= Insert amount (ng) (2.1)
Once the DNA ligation was completed, 5 or 10 µL were used to transform 50 or 100 µL of
chemically competent NZY5a cells (NZYtech), according to the instructions of themanufacturer.
However, 0.6 milliliters (mL) of warm (37 ºC) liquid SOC Medium (NZYTech) were added and
the cells were shaken for more than 1 h (typically, 1.5 h). Then, the cells were centrifuged at
0.5 xG for 5 min and the cell pellet was resuspended in 100 µL of SOC, which were then plated
on ampicillin plates (100 µgampicilin / mLLBagar (w/v)) and incubated for 16 h. The resulting
colonies were screened by performing a colony PCR. Briefly, 1-3 positive colonies were picked
and cultivated in ampicillin supplemented LB medium for 16 h at 37 ºC with vigorous shaking
(225 rpm). To isolate and purify the plasmid from bacteria we resorted to the NZYMiniprep
kit from NZYtech and followed the manufacturer’s protocol. The only changes to this protocol
were the addition of an additional washing step with Bu↵er A4 and the subjection of the kit’s
column to the same volume of AE twice, i.e., repetition of the elution step, to increase the
elution e ciency. After measuring the concentration of the plasmid DNA, 1 µg of DNA was
sent, together with the desired primer(s), to STAB VIDA for sequence verification through
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Sanger sequencing. The results were then analyzed with Clustal Omega Multiple Sequence
Alignment (Sievers et al., 2011).
2.7 Genomic DNA (gDNA) extraction
To extract gDNA from cells in culture, we used the High pure PCR Template Preparation
kit from ROCHE. Briefly, the cells were resuspended in the medium and transferred to a 1.5
mL eppendorf. The cells were then centrifuged at 0.8 xG for 3 min and resuspended in 200 µL
of PBS. After that, the same volume of Binding Bu↵er and 40 µL of 20 mg/mL proteinase K
were added before mixing and incubation for 10 min at 70 ºC. Isopropanol was added prior to
the inhibition and washing steps. Finally, the gDNA was eluted in 50 µL of pre-warmed elution
bu↵er and stored at -20 ºC for further analysis.
Regarding the extraction of gDNA from flies, the brain of male flies aged 3-7 days or the
CNS of wandering 3rd instar larvae were dissected and collected. To maintain consistency
among the experiments, only male flies were used. The methods used in the extraction of
these 2 di↵erent samples were di↵erent: we followed High pure PCR Template Preparation
kit manual to extract the gDNA from Larvae brains, whereas the gDNA from adult brains was
extracted with DNA extraction bu↵er (10 mM Tris-Chlorine (Cl) at pH 8.2, 1 mM EDTA, and
25 mM Sodium chloride (NaCl), hereafter referred to as bu↵er A) (Carvalho et al., 2009). The
Bu↵er A extraction protocol consists in the maceration of flies using pellet pestles and 100 µL
of Bu↵er A. Once macerated, the samples are treated with 1 µL of proteinase K (Roche) and
incubated at 37 ºC for 1 h. After this period, proteinase K is inactivated by a 5-min incubation
at 95 ºC. Lastly, a centrifugation step of 5 min at 5.0 xG allows the separation of tissue and
cellular debris, which stay in the bottom, from the gDNA that remains in the supernatant.
2.8 RNA extraction
To characterize and evaluate the relative L1 and AlumRNA levels in the transgenic fly lines,
total RNA was extracted from the heads of 1 to 2 days old male flies (Table 2.4) using both
trizol (Tripure Isolation Reagent, Roche) and a spin column-based RNA purification kit (High
Pure RNA Tissue kit, Roche) and DNAse-I treated, following instructions of the manufacturers.
Briefly, heads were macerated using pellet pestles and homogenized in 800 µL trizol. Posteriorly,
the samples were transferred to a purifying column where they were treated with DNAse I,
washed and eluted in the minimal volume possible to assure higher concentrations of RNA.
A second DNAse treatment, TURBO DNA-freeTM Kit enzyme (Invitrogen), was exploited to
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prevent gDNA contamination. The RNA concentration of each sample was measured using a
NanodropTM 2000 spectrophotometer.
Table 2.4: List of the genotypes tested, the number of collected heads and the RNA concentra-
tion obtained.
Driver Gene of interest # heads RNA concentration (ng/µL)
BDP > L1a 32 199.1
BDP > L1b 32 182.9
BDP > L1c 51 243.9
BDP > L1d 26 162.8
BDP > L1e 36 185.5
BDP > L1f 40 205.0
BDP > L1g 41 204.7
57C10 > L1a 46 226.8
57C10 > L1b 37 200.9
57C10 > L1c 31 195.4
57C10 > L1d 31 191.1
57C10 > L1e 32 210.7
57C10 > L1f 37 209.7
57C10 > L1g 36 233.7
Tubulin > Alua 73 371,8
Tubulin > Alub 59 254,6
Tubulin > Aluc 78 363,0
Tubulin > Alud 66 328,9
Tubulin > Alue 34 224,2
Tubulin > Aluf 58 314,3
Tubulin > Alug 48 234,2
Tubulin > Aluh 64 330,7
Tubulin > Alui 45 305,2
2.9 Complementary DNA (cDNA) preparation
cDNA was prepared for RT-qPCR analysis from DNAse-TURBO treated RNA samples. For
this purpose, Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Scientific) was
used, according to the manufacturer’s protocol, for a total volume of 10 µL per reaction. After-
wards, the cDNA samples were diluted at least 3 times (for a final volume of 30 µL or more) to
prevent any eventual inhibition of the RT-qPCR reaction caused by reagents used during the
cDNA synthesis. To test for gDNA contamination in the RNA samples, all the samples used for
the cDNA synthesis were simultaneously used in a parallel reaction in which the reverse tran-
scriptase enzyme was replaced by MilliQ water. These additional reactions are called reverse
transcriptase negative controls (RT- controls).
2.10 Reverse Transcriptase quantitative PCR (RT-qPCR)
RT-qPCR was performed using the FastStart Essential DNA Green Master dye and poly-
merase (Roche) and a Lightcycler®96 (Roche). The final volume for each reaction was 10 µL,
consisting of 5 µL of dye and polymerase (master mix), 2 µL of cDNA sample and 3 µL of
specific primer pairs (1 µM) (Table 2.3). The relative L1 and AlumRNA levels were determined
according to Equation 2.2. The geometric means ± SD of 3 technical replicates were plotted.
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%rp49 = 2
 ( Cqx  Cqrp49) ⇥ 100 (2.2)
where: x = L1 or Alu, rp491 = control
The RT-qPCR program used is depicted in Table 2.2. The fluorescent intensity of SYBR
Green was surveyed at the end of each extension step.
2.11 Cell culture conditions, DNA preparation and transfection
Drosophila line 2 (DL2) cells, also known as Schneider 2 (S2), are spherical semi-adherent
cells likely derived from a macrophage-like lineage. DL2 stem from a primary culture of late
stage (20 to 24 h old) D. melanogaster embryos (Schneider, 1972). DL2 cells were cultured in
Schneider’s Drosophila Medium (Biowest) supplemented with 10 % (v/v) of heat-inactivated
Fetal Bovine Serum (FBS, Life Technologies) and 1 % (v/v) of antibiotic solution (Penicillin-
Streptomycin (Pen-strep), Sigma). The cells were maintained in T25-flasks at 25 ºC under
normal atmospheric conditions. DL2 cells were subcultured every 3 to 4 days in a cell medium
ratio of 1:20, upon reaching 80-90 % cell confluency, to maintain an appropriate mitotic index
and to avoid cell death triggered by nutrient absence.
Plasmid DNA was purified using NZYtech miniprep columns, according to the guidelines
of the manufacturer. DNA quality was checked by electrophoresis in 0.7 % agarose – GreenSafe
gels. Only high quality plasmids were used for transfection.
For transient transfections, 2 x 105 DL2 cells were seeded per well (in 24-well plates) in
medium without antibiotics. Upon reaching 80 % cell confluency, 24 h after seeding, DL2 cells
were transfected with a mixture containing 1 µg of total plasmid (each plasmid in equimolar
amounts), FuGENE® HD Transfection Reagent (Promega) in a 1:3 DNA (µL)/ FuGENE (µL)
ratio, and Schneider’s Drosophila Medium (up until 25 µL) per well. After a 10 min incubation,
the plasmid mixture was added to the cells, which were posteriorly incubated at 25 ºC. 48 or
96 h after incubation, the cells were either fixed and stained or harvested and processed for
subsequent analysis. The transfections were made in duplicates.
2.12 Immunostaining
Brains from both wandering 3rd instar larvae and adult flies aged 3-7 d were dissected
in Schneider’s Drosophila Medium and fixed in 4 % (v/v) Formaldehyde (Sigma) diluted in
1X PBS. Brains were dissected and stained as described by Weitkunat and Schnorrer, 2014.
1rp49 or Ribosomal protein L1 32 gene, RpL32, is an endogenous and constitutively expressed gene inDrosophila.
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Briefly, after having their posterior end cut out, larvae were inverted through their anterior end,
leading to the exposure of their brain. For the adult brains, the dissection procedure consisted
in decapitation, then making a shallow incision with a forceps in the region between the eye
and the proboscis. Next, the eye capsule and the rest of the cuticle are removed while holding
the proboscis down. Once the brains were dissected, they were fixed for 20 min in shaking
conditions and washed in 0.3 % (v/v) PBS-Triton X-100 (PBT). All tissue samples were blocked
in 1 % (w/v) Bovine Serum Albumin (BSA) in PBT blocking solution for at least 1 ON (and up
until 48 h) at 4 ºC while shaking. Subsequently, the samples were stained with the primary
antibodies at 4 ºC for 48 h while shaking. Then, the tissues were washed 3x (or more) with PBT
for 30 min and incubated ON at 4 ºC with the secondary conjugated antibodies in the shaker.
The samples were washed 3x in PBT and nuclei were stained by incubating the samples in 0.001
% (w/v) of DAPI (Sigma) for 10-15 min at RT while shaking. After washing 3x with either PBT
and PBS, the tissues were mounted by transferring them to a previously prepared slide (that
has 2 coverslips flanking a region in the middle in which the tissues are put), by removing all
the tissues that are attached to the brain, and by adding mounting medium (16 mL Glycerol, 4
mL PBS 1X and 0.4 g DABCO (Sigma)). Typically, 5–10 brains were mounted for each genotype
and 1 representative image per genotype is depicted in the figures.
A similar immunocytochemistry protocol was used with DL2 cells, but the incubation times
and the washing solutions were di↵erent. 48 h or 96 h after transfection, the cells were fixed in
4 % (v/v) formaldehyde solution for 20 min. Subsequently, the fixed cells were permeabilized
with 0.1 % (v/v) PBT for 10 min. Cells were then washed with PBS, incubated with 1 %
(w/v) PBS-BSA for 1 h at RT, and posteriorly incubated with the primary antibody either ON
at 4 ºC or for 2 h at RT. Cells were subsequently washed and incubated with the secondary
antibody, away from light, for a minimum of 2 h at RT. Finally, after a 0.001 % (w/v) DAPI
incubation for 10 min (away from light), the coverslips were mounted on the slides. Typically,
5–15 microphotographs were taken for each well and 1 representative image per genotype is
depicted in the figures.
Primary antibodies used for immunofluorescence include: rabbit polyclonal anti-GFP (Life
Technologies, A11122), mouse monoclonal anti-gH2AV (DSHB, UNC93-5.2.1-S), and mouse
monoclonal anti-ORF2p (Kerafast, ETL001). The secondary antibodies used were: goat Alexa
fluor 488 anti-rabbit (Invitrogen, A11070), goat Alexa fluor 488 anti-mouse (Life Technologies,
A11029), Alexa fluor 594 goat anti-mouse (Invitrogen. A11020), goat FarRed (Cy5) anti-mouse
(Jackson Immuno Research, 115-175-166). Additional information on the antibodies and dilu-
tions used is depicted in Table 2.5.
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Table 2.5: List of primary and secondary antibodies used for the immunostaining procedures.
Antibodies Conjugated Recognize Host Concentration Supplier
GFP Rabbit 1:200 (tissue) Life Technologies
1:500 (cells)
Primary gH2AV Mouse 1:500 (tissue) DSHB
1:2500 (cells)
L1_ORF2p Mouse 1:20 (tissue) Kerafast
1:50 (cells)
Alexa Fluor 488 rabbit antibodies Goat 1:250 Invitrogen
Secondary Alexa Fluor 488 mouse antibodies Goat 1:250 Life Technologies
Alexa Fluor 594 mouse antibodies Goat 1:250 Invitrogen
Far Red (Cy5) mouse antibodies Goat 1:250 Jackson Immuno Research
2.13 Microscopy and image analysis
Images were acquired with a Zeiss Z2 widefield fluorescence microscope equipped with a
Plan-Apochromat 20x air, an EC Plan-NeoFluar 40x oil immersion and a Plan-Apochromat 63x
oil immersion objective lens (NA 0.80, 0.75 and 1.40, respectively) or with a Zeiss LSM 710
Confocalmicroscope. To compare the levels of the desired proteins between di↵erent conditions,
each condition was imaged with the same settings. Exposure time and Laser intensity were
set on the brightest condition and reused on the remaining conditions. Images were processed
with Fiji (Schindelin et al., 2012).
2.14 Statistics
Fly locomotor ability data were recorded in Microsoft Windows Excel spreadsheet and
plotted, with R, in box plots representing median, 25 and 75 % quartiles (Tukey’s method).
Whiskers extend to 1.5 times the IQR. Values above or below the whiskers are considered
outliers. A two-way analysis of variance (ANOVA) was performed to determine significant
e↵ects of L1 expression on each day of assay. Alpha was set at 0.05 to consider statistical
significance. Data from the relative expression of UAS-L1 and Tub-Alu[Act-sfGFP] transgenic
lines were plotted in bar plots with GraphPad.
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RE derepression has been associated with age-dependent neurophysiological decline, which
is aggravated in neurodegenerative diseases (Guo et al., 2018; Krug et al., 2017; Li et al., 2013;
Tan et al., 2011; reviewed in Dubnau, 2018). However, it is not clear whether RE derepression is
a cause or consequence of ageing and related neurodegenerative diseases. To test the hypothesis
that RE expression causes the neuronal decline associated with ageing, our strategy was to
generate an heterologous system where human L1 expression is spatially controlled in an
animal naïve to this RE, the Drosophila fly. With this system, we can express human L1 in fly
neurons and quantify neuronal function of young and aged flies using a negative geotaxis assay.
3.1 UAS-L1 transgenic lines respond to neuronally-expressed GAL4
The negative geotaxis assay, also known as climbing assay, is a widely used functional
assay to monitor locomotor behavior and its age-dependent decline in Drosophila (Figure 2.1).
This assay is based on the negative geotactic response that Drosophila displays when startled.
WT Drosophila respond robustly to this assay when young (e.g., 2 day-old flies after eclosion),
resulting in the rapid climbing of the flies to the top of the vial. As flies age, this ability is
gradually lost and they are no longer able to climb to the top of the vial (A). Hence, the longer
the flies take to reach the top of the tube, the worse is their locomotor behavior. Having this
and our hypothesis in mind, we expect a significantly decreased percentage of flies in the top
of the tube when L1 is expressed in the fly neurons.
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To restrict the expression of L1 to neurons in the fly, we resorted to the GAL4-UAS system
(Figure 1.6) as depicted in Figure 3.1.A. For this purpose, transgenic lines containing the UAS-
L1 construct were successfully generated. In order to see whether these transgenic lines were
responding to GAL4, we crossed each UAS-L1 (hereafter, >L1) line with a transgenic stock
line containing a pan-neuronal promoter regulating the expression of a GAL4, 57C10, and
determined the relative expression of L1 in the o↵spring (57C10>L1) brain using RT-qPCR
(Figure 3.1.B). The relative expression was then compared with a control driver condition in
which each UAS-L1 transgenic line was crossed with a stock line, pBDP-GAL4. pBDP> carries
an "empty" GAL4 driver, identical to the 57C10> line (i.e., has the same genetic background),
but without the neuronal enhancer. Hence, pBDP>L1 flies are expected to have no (or basal)
expression of L1. GAL4-dependent induction of UAS-L1 expression in neurons caused an
observable increase of L1 transcription in 6 out of the 7 tested lines, ranging from 15- to 205-
fold compared to the control. The two lines with the largest fold increase in L1 mRNA levels,
L1a and L1e, were used in the following experiments.
3.2 Forced expression of L1 does not a↵ect neuronal function
To test whether neuronal L1a expression has any e↵ect on locomotor activity throughout the
ageing process, we collected 57C10>L1a flies and submitted them to the climbing assay 2, 20,
and 40 days after eclosion, as portrayed in Figure 2.1. We included two additional independent
neuronal drivers, nSyb-GAL4 and elav-GAL4 to ensure robustness of our results. The tested
animals were obtained by crossing the L1a transgenic line with the respective driver stocks. To
control for background and transgene insertion e↵ects, we also assayed animals from several
control genotypes. These included animals obtained from crosses between the driver lines and
the background control stock, w[1118] (nSyb>, elav> and 57C10>), between the control driver
line pBDP> and the >L1a line (pBDP>L1), and between the >L1a stock and w[1118] (>L1a).
The forced expression of L1 in D. melanogaster neurons throughout lifespan did not signif-
icantly a↵ect the results of the climbing assay (Figure 3.2.A). Though 57C10>L1 flies had a
statistically significant decrease in the locomotor ability compared to di↵erent controls at age
20 (days), the same was not observed when L1 expression was driven by the other neuronal
drivers, nSyb> and elav> (Table A.2, Appendix A). Therefore, we conclude that neuronal L1
expression has no detectable e↵ect on fly locomotor activity as measured in the climbing assay.
This suggests that L1 expression in neurons does not worsen the neurofunctional decline that
is associated with ageing in flies.
To confirm the results obtained with the first line, we next tested the UAS-L1e transgenic
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Figure 3.1: UAS-L1 transgenic lines are responsive to a pan-neuronal GAL4 driver. (A)
Schematic representation of the protocol followed to determine the responsiveness of the UAS-
L1 transgenic lines to the neuronally-expressed GAL4. Seven UAS-L1 transgenic lines (>L1a-
L1g) were crossed to the pan-neuronal GAL4 driver 57C10> or the negative control driver
(pBDP>). RNAwas then extracted from the heads of the resulting flies and relative L1 transcript
levels were determined by RT-qPCR. (B) Bar plot of the relative abundance of L1 transcripts,
namely L1 ORF2, in adult heads of seven transgenic fly lines carrying independent insertions
of the UAS-L1 transgene (>L1a-g) crossed to the pan-neuronal GAL4 driver 57C10> (orange
bars) or the negative control driver pBDP> (light blue bars). Values represent geometric means
± SD of L1 mRNA levels relative to rp49 levels (rp49 = 100 %). The bars have been ordered
according to the largest to smallest fold-induction of L1 expression.
45
CHAPTER 3. RESULTS
A
B
>L1a
(312
) pBD
P>L
1a
(176
) 57
C10
>
(137
) 57C
10>L
1a
(166
)pB
DP>
(187
) nS
yb>
(171
) nSy
b>L1
a
(180
) e
lav>
(176
)
CONTROL 57C10 nSyb elav
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
0
25
50
75
100
Age
●
●
●
2 Day−old
20 Day−old
40 Day−old
elav
>L1a
(138
)
Pe
rc
en
ta
ge
of
m
al
es
 a
bo
ve
6 
cm
 a
fte
r5
 s
 (%
)  
 Locomotor Capacity (L1a)
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
● ●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
0
25
50
75
100
Age
●
●
2 Day−old
40 Day−old
pBDP>L1
(247)
Locomotor Capacity (L1e)
>L1
(236)
57C10>
(241)
57C10>L1
(272)
Control 57C10
Pe
rc
en
ta
ge
of
m
al
es
 a
bo
ve
6 
cm
 a
fte
r5
 s
 (%
)
A E CD HG B FG D G
Figure 3.2: Forced expression of L1 in Drosophila neurons throughout lifespan does not
a↵ect neuronal function. (A) UAS-L1a flies were crossed to three pan-neuronal GAL4 drivers
57C10>, nSyb> and elav> or the negative control driver (pBDP>) or the background control
(w[1118]). The GAL4 drivers were also crossed to w[1118]. The flies locomotor behavior was
scored as the percentage of males above 6 cm 5 seconds after initiating the assay. (B) UAS-L1e
flies were crossed to 57C10>, pBDP> and w[1118]. A GAL4 driver control included the cross of
57C10> to w[1118]. (A-B) Box plot showing the anti-gravitational response of male flies at 2, 20,
and 40 days after eclosion or at 2 and 40 days after eclosion for A and B, respectively. Numbers
below the genotype represent the number of individuals (N) tested for each genotype. Whiskers
extend to the smallest and the largest value that are at most 1.5 times the IQR (Tukey’s method).
Black bars represent the median. Dots beyond whiskers are outliers. p < 0.05, Tukey’s multiple
comparisons test. Genotypes sharing the same letter (black) are not statistically di↵erent at a =
0.05.
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line using the 57C10> pan-neuronal driver and assaying for locomotor behavior 2 and 40 days
after eclosion (Figure 3.2.B). Again, no statistically significant reduction in locomotor activity
was detectable upon L1 expression under the control of the 57C10 driver, when compared to
all controls.
Taken together, these results demonstrate that expression of human L1 in the fly nervous sys-
tem does not lead to a detectable loss of locomotor capacity. However, to conclude that increased
human L1 retrotransposition does not alter neuronal function in flies, we must demonstrate
that human L1 is capable of retrotransposition in fly neurons.
3.3 Human L1 ORF2p is translated in D. melanogaster
In order to mediate retrotransposition, L1must be transcribed and the peptides it encodes,
ORF1p and ORF2p, translated (Moran et al., 1996). Our results above demonstrate that human
L1 is transcribed in D. melanogaster neurons upon GAL4-dependent activation (Figure 3.1.B).
Nevertheless, whether or not Drosophila cells are capable of translating L1 ORFs remain to be
tested. Di↵erences in codon usage preferences or capability to recognize ribosomal entry sites
could compromise the ability of the D. melanogaster translation machinery to translate human
L1 ORFs, especially the second ORF, ORF2, of the L1 mRNA, which is already translated at
a very low relative e ciency (~30% relative to ORF1) in human cells (Dmitriev et al., 2007;
Taylor et al., 2013).
To test if human L1 ORF2 is translated into ORF2p in D. melanogaster cells, we expressed
full-length human L1 in Drosophila cells in vitro and in vivo and monitored L1 ORF2 expression
by immunofluorescence assays using a specific mouse monoclonal antibody raised against the
human ORF2p (Sokolowski et al., 2014). The in vitro experiments consisted in co-transfecting
DL2 cells with a plasmid containing pUAS-L1 and a plasmid containing a constitutively-active
GAL4 (pAct-GAL4, hereafter pAct-GAL4) and collecting the cells 48 h later for the immunoflu-
orescence assays (Figure 3.3.A). Negative controls consisted in untransfected cells and cells
transfected with either plasmid alone in equimolar concentrations, as described in detail in
Chapter 2, Section 2.11. The results obtained showed positively-stained cells for anti-ORF2p,
albeit infrequent, only in the condition where both pAct-GAL4 and pUAS-L1 plasmids were
co-transfected (Figure 3.3.B, Figure 3.3.C). The low frequency of ORF2p-positive cells was
not due to problems related with transfection e ciency, because when we repeated the whole
experiment with a transfection control plasmid, pUAS-GFP, we saw the same low frequency
of anti-ORF2p-positive cells, despite plentiful GFP expression (data not shown). These results
demonstrate that ORF2p can indeed be translated from full-length bicistronic L1 mRNA in
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Drosophila cells.
To test if we could detect ORF2p expression in vivo, we performed immunofluorescence
assays with the anti-ORF2p antibody on dissected CNSs of 3rd instar 57C10>L1 larvae, and
compared them to the CNS from control pBDP>L1 larvae (Figure 3.4.A). In contrast to the in
vitro experiments, no anti-ORF2p positive staining was detected in any condition, as shown in
Figure 3.4.B. These results could either suggest that human ORF2 translation is less e cient in
neurons or that our CNS immunofluorescence conditions were not optimal for ORF2p detection.
3.4 L1 does not induce DNA damage in Drosophila melanogaster
Both successful and failed L1 retrotransposition attempts produce DNA damage, such as
DNA DSBs (Gasior et al., 2006; Belgnaoui et al., 2006). We therefore considered that if L1 was
competent for retrotransposition in Drosophila, its expression in Drosophila cells should lead
to a detectable increase in DSBs. To quantify DSBs formation in vitro, we stained Drosophila
cells co-transfected with pAct-GAL4 and pUAS-L1 with a mouse monoclonal antibody raised
against g-H2AV and compared them with untransfected cells or a series of control transfections
(Figure 3.5.A) (Lake et al., 2013). g-H2AV is a phosphorylated variant of the histone H2A in
Drosophila that accumulates mainly in DSBs sites, but also in re-replication sites in endocycling
cells (Rogakou et al., 1998; Rogakou et al., 1999; Lake et al., 2013). Experimental studies in
human cells have shown that retrotransposition frequency correlates with the number of g-
H2AX foci (H2AX is the human H2A variant involved in the process of DSB repair) (Farkash
et al., 2006). Figure 3.5.B shows no observable increase in the number of cells with foci, nor in
the number of foci per cell when pAct-GAL4 and pUAS-L1 are co-transfected together. These
results suggest that L1 proteins do not induce detectable levels of DSBs in Drosophila cells.
To assess DSBs formation in vivo, we performed immunofluorescence assays with the anti-
g-H2AV antibody on dissected CNSs of 3rd instar 57C10>L1 larvae, and compared them to the
CNS from control pBDP>L1, >L1, and 57C10> larvae (Figure 3.6.A). As demonstrated in Figure
3.6.B, the expression of L1 in fly neurons (57C10>L1) is not associated with an increase in DSBs,
because the anti-g-H2AV stained CNSs of those animals show no noticeable di↵erences when
compared to the CNSs of >L1 and 57C10> control animals. Even though the complexity of the
fly CNS represents an additional obstacle to the immunohistochemistry procedures, because
the antibody has to di↵use and penetrate every cell in order to have a trustworthy staining,
these results are consistent with the results obtained in vitro (Figure 3.5.B), and suggest that L1
expression does not induce detectable levels of DSBs in the fly genome.
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Figure 3.3: Human L1 ORF2p is translated in DL2 cells. (A) Representative scheme of the in
vitro approach used to detect the L1 ORF2 protein (ORF2p). DL2 cells were co-transfected with
equimolar concentrations of an pActin-GAL4 (pAct-GAL4) and a pUAS-L1 plasmids, and stained
with a mouse monoclonal antibody raised against the human ORF2p (anti-ORF2p) followed by
a secondary antibody coupled to Alexa Fluor 488 (hereafter, referred to as anti-ORF2p staining).
(B) Representative fluorescence photomicrographs of cells co-transfected with the respective
plasmids (left labels). Anti-ORF2p (green channel). Nuclei were counterstained with DAPI
(blue). White arrowheads highlight anti-ORF2p positive cells. n = 2 technical replicates, i.e., 2
wells per condition. Scale bar represents 100 µm. The white arrowheads highlight the positive
staining for ORF2p (cells producing ORF2p). (C) Detail of an ORF2p-positive cell. Scale bar
represents 50 µm.
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Figure 3.4: Human L1 ORF2p is not detectable in vivo in Drosophila CNS. (A) Schematic
representation of the in vivo experiments used to detect the human L1 ORF2p. UAS-L1a flies
were crossed to the pan-neuronal GAL4 driver 57C10>, the control driver pBDP> and the
background control w[1118]. 57C10> crossed to w[1118] served as an additional driver control.
The CNS of 3rd instar larvae from the previous crosses were isolated and stained with the anti-
ORF2p antibody. (B) Sum of confocal Z-stack slices of 3rd instar larvae CNS with the respective
labels (left), stained with anti-ORF2p (Green), and counterstained with DAPI (Blue). Scale bar
represents 100 µm. 50
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Figure 3.5: L1 expression does not induce DSBs in DL2 cells. (A) Flow chart of the in vitro
experimental design to detect DNA damage. Like before, DL2 cells were co-transfected with
equimolar amounts of pActin-GAL4 (pAct-GAL4 pUAS-L1, and pUAS-GFP plasmids, and stained
with a mouse monoclonal antibody raised against g-H2AV (used here as a biomarker for DSBs
followed by a secondary antibody coupled to Alexa Fluor 594 (hereafter referred to as anti-g-
H2AV staining). (B) Representative fluorescence photomicrographs of cells transfected with
the respective plasmids (left labels). pUAS-GFP serves as control for transfection (green) and
was added in every condition except in the untransfected control. Anti-g-H2AV (red channel).
Nuclei were counterstained with DAPI (blue). n = 2 technical replicates. Scale bar represents
100 µm. (C) Detail of anti-g-H2AV staining (green). DAPI (nuclei, blue). Scale bar represents
10 µm.
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Figure 3.6: L1 expression does not induce DSBs in the Drosophila larval CNS. (A) Represen-
tative illustration of the experimental design used to detect DNA damage in vivo. CNSs of 3rd
instar larvae were collected and stained with the anti-g-H2AV antibody. The genotypes ana-
lyzed were the same as Figure 3.4.B: 57C10>L1 and the controls >L1, pBDP>L1, and 57C10>.
(B) Sum of confocal z-stack slices of 3rd instar larvae CNS with the respective labels (left).
anti-g-H2AV (green), DAPI counterstain (nuclei, blue). Scale bars represent 100 µm.
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3.5. TUB-ALU[ACT-SFGFP] TRANSGENIC LINES CONSTITUTIVELY EXPRESS ALU.
3.5 Tub-Alu[Act-sfGFP] transgenic lines constitutively express Alu.
Besides mediating self-retrotransposition in cis, human L1s also non-autonomously retro-
transpose SINEs (Dewannieux et al., 2003, Dewannieux and Heidmann, 2005, Hancks et al.,
2011, Hancks et al., 2012). Having this in mind, we generated a retrotransposition reporter
element based on the human SINE, Alu, whose cellular readout is the production of GFP. As
illustrated in Figure 3.7.3, we placed a GFP reporter cassette inside the Alu sequence at a po-
sition towards its 3’ region, which should not interfere with Alu activity (Dewannieux et al.,
2003). The GFP reporter cassette comprises a sfGFP sequence preceded by the constitutive
Drosophila actin promoter and followed by an eukaryote transcription termination signal, SV40
(Act-sfGFP). The sfGFP sequence is disrupted by the MhcInt16 intron from D. melanogaster,
which was placed in the opposite direction of the Act-sfGFP sequence (Figure 2.3). To ensure
the production of the reporter element, Alu[Act-sfGFP], we put it under the regulatory control
of the constitutive Drosophila Tubulin promoter (Tub-Alu[Act-sfGFP]). Therefore, retrotranspo-
sition can be monitored by direct inspection for GFP activity in transfected cells in vitro, or in
cells of transgenic animals in vivo (Figure 3.9).
Figure 3.7: Schematic illustration of the human LINE/SINE system used in the retrotrans-
position assays. (1) A promoter drives the expression of GAL4 (blue diamond), which (2) binds
to an UAS sequence, leading to the expression of L1 proteins (orange circles). (3) A Drosophila
Tubulin promoter (Tub) regulates the expression of the human SINE, Alu (Tub-Alu[Act-sfGFP]),
which has a sfGFP cassette in the opposite sense. The sfGFP cassette comprises the constitutive
Drosophila Act5c promoter followed by a sfGFP sequence which is interrupted by the inverted
Drosophila MhcInt16 ([Act-sfGFP]). (4) Only after splicing and a successful round of retrotrans-
position (mediated by L1 proteins), the sfGFP protein (green cylinder) will be produced.
We started by testing the system in vitro by co-transfecting DL2 cells with equimolar
amounts of pTub-Alu[Act-sfGFP], pUAS-L1, and pAct-GAL4 plasmids. However, we were unable
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to detect the production of intronless sfGFP in a reproducible manner, neither by immunocyto-
chemistry procedures, nor via amplification of the gDNA extracted from transfected cells (data
not shown). While a positive GFP-stained cell would have been proof of retrotransposition,
there is less confidence to conclude that the absence of GFP-positive cells means that there is no
retrotransposition in trans between L1 and Alu in Drosophila cells. Many factors can a↵ect this
result, such as the limited frequency of triply co-transfected cells and the fact that successful
retrotransposition of full-length elements is not expected to be a highly frequent event.
The limitation of co-transfections could be surmounted in vivo by generating transgenic
animals. Thus, we generated and characterized transgenic flies carrying the Tub-Alu[Act-sfGFP]
construct. As shown in Figure 3.8, Alu[Act-sfGFP] transcripts were detected in all tested lines,
although their abundance varied 5 orders of magnitude. This variation in expression level could
be due to positional e↵ects of the transgene insertions.
Figure 3.8: Alu expression levels in Tub-Alu[Act-sfGFP] transgenic lines. Bar plot with the
relative AlumRNA levels (determined by RT-qPCR) in adult heads of nine transgenic fly lines
carrying independent insertions of the Tub-Alu[Act-sfGFP] transgene. Values represent the
geometric mean ± SD of three technical repeats of estimated AlumRNA levels relative to rp49
mRNA levels(rp49 = 100 %). Data was sorted in a descending order according to the relative
AlumRNA levels (% rp49, above the bars).
3.6 Human L1 does not retrotranspose Alu in fly neurons.
To directly test the L1/Alu system in vivo, we generated a line expressing the UAS-L1a and
Tub-Alu[Act-sfGFP] transgenes (by crossing UAS-L1a flies to Tub-Alub flies; here referred to
54
3.7. ORF2P CANNOT RETROTRANSPOSE A HUMAN ALU IN D. MELANOGASTER.
as UAS-L1a and Tub-Alu[Act-sfGFP]) (Table 2.1), which we crossed to a stock carrying the pan-
neuronal GAL4 driver, 57C10>, or to the negative GAL4 driver control, pBDP>. Then, the
CNS of 3rd instar larvae and the brain of 3-7 day-old adult flies resulting from the previous
crosses were isolated and stainedwith a rabbit polyclonal antibody raised against GFP, anti-GFP
(Figure 3.9.A).
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Figure 3.9: Human L1 does not mediate Alu retrotransposition in trans in fly neurons. (A)
Schematic diagram of the retrotransposition assays performed in vivo. Flies containing both
UAS-L1a and Tub-Alu[Act-sfGFP] transgenes were crossed to the pan-neuronal GAL4 driver line
57C10> or to the negative driver control line pBDP>. The CNS of 3rd instar larvae and the brain
(CNS without the ventral nerve cord) of adult individuals (aged between 3-7 days) resulting
from the previous crosses were stained with a rabbit polyclonal antibody raised against GFP,
anti-GFP, followed by a secondary antibody coupled with Alexa Fluor 488 (hereafter referred
to as anti-GFP staining). (B) Representative fluorescence photomicrographs of 3rd instar larvae
CNS (left panel) and adult brains (right panel) of the respective genotypes (labels on the left).
Anti-GFP staining (green). Scale bars represent 100 mm
We detected no di↵erence in anti-GFP staining in the larval CNS or adult brain of 57C10>L1a
animals compared to the CNS and adult brains of pBDP>L1a control animals (Figure 3.9.B).
Consistently, the same results were observed in nSyb>L1a animals (data not shown). These
results suggest that L1 is not able to mediate Alu retrotransposition in trans in Drosophila neu-
rons.
3.7 ORF2p cannot retrotranspose a human Alu in D. melanogaster.
We next sought ways to overcome the ine cient translation of the human ORF2p from
the L1 bicistronic mRNA in Drosophila. The rationale was that a higher e ciency of ORF2p
translation could lead to higher, and therefore, detectable, retrotransposition rates. According
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Figure 3.10: Rationale of the retrotransposition assay performed in DL2 cells. Representa-
tive scheme of the in vitro approach used to detect the successful retrotransposition events using
the LINE/SINE reporter system. DL2 cells were co-transfected with equimolar concentrations
of pActin-GAL4, pUAS-ORF2, Tub-Alu[Act-sfGFP], and pUASp-moesin::mCherry plasmids, and
stained with a rabbit polyclonal antibody raised against GFP (anti-GFP) followed by a secondary
antibody coupled to Alexa Fluor 488 and with anti-ORF2p staining as described in Figure 3.3.
to Dewannieux et al. (2003), the human L1 ORF2p is su cient to mediate the non-autonomous
retrotransposition of human Alu. Therefore, we attempted to increase ORF2p levels by facil-
itating its translation by replacing the full-length L1 (pUAS-L1) by the ORF2 sequence alone
(pUAS-ORF2) (Figure 3.10). The idea is that higher ORF2p translation rates would occur if the
ORF2 was the first ORF to be translated, rather than being second in the bicistronic L1mRNA.
We found that the number of DL2 cells stained with anti-ORF2p was higher and similar to
the number of membrane-organizing extension spike protein (moesin)::mcherry-positive cells
when pAct-GAL4 was co-transfected with pUAS-ORF2 instead of pUAS-L1 (Figure 3.11.A - last
panel row, Figure 3.3.B). Thus, with this strategy we were able to overcome the human L1 ORF2
low translation e ciency observed before (Figure 3.3.B and 3.3.C). Very rarely, we found one
or two cells positive for anti-ORF2p when DL2 cells were co-transfected with pUAS-ORF2 and
pTub-Alu[Act-sfGFP] but without pAct-GAL4 (Figure 3.11.A, second row in the panel). This is
interpreted as leakiness of the pUAS-plasmid.
As regards the pTub-Alu[Act-sfGFP] retrotransposition reporter, results of the transfection
experiments demonstrate similar anti-GFP staining in cells regardless of the presence or absence
of pUAS-ORF2 in the co-transfection mixture (middle vs. bottom panel rows; Figure 3.11.A and
Figure 3.11.B). Similar results were obtained when cells were collected 96 h after transfection
(data not shown). Furthermore, we were unable to detect the production of intronless sfGFP
via amplification of the gDNA extracted from transfected cells (data not shown). These results
suggest that ORF2p is insu cient to retrotranspose Alu in Drosophila DL2 cells.
Curiously, co-transfected cells with both pUAS-ORF2 and pAct-GAL4 displayed a reduction
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in the intensity of moesin::mcherry (Figure 3.11.B). We also noticed that the number and the
length of DL2 cells projections per se appear to be reduced when ORF2p is produced, but it is dif-
ficult to exclude that this is an impression caused by the reduced expression of moesin::mcherry
per se. Regarding these observations, we speculate that ORF2p might somehow interfere with
moesin::mcherry production or stability.
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Figure 3.11: Human ORF2p is not su cient to retrotranspose Alu in DL2 cells. (A) Repre-
sentative fluorescence photomicrographs of the retrotransposition assay performed in DL2 cells
to detect GFP production. Expression of ORF2p instead of full-length L1 results in a higher ef-
ficiency of translation (magenta) but it is not su cient to retrotranspose Alu in D. melanogaster
(green). pUASp-moesin::mcherry (in red) is a transfection control plasmid that highlights the
actin cytoskeleton of DL2 cells. The presence of L1 leads to a decrease in moesin fluorescence
intensity. n = 2 technical and 2 biological replicates per condition. +,- represent the pres-
ence or absence of the plasmid, respectively. Scale bars represent 100 µm (B) Fluorescence
photomicrographs detailing transfected DL2 cells more closely. Scale bars represent 100 µm.
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Discussion
Ageing is the main risk factor for developing neurodegenerative diseases. Previous studies
have suggested that during ageing, the RE repressing mechanisms tend to fail and REs become
activated (De Cecco et al., 2013a; De Cecco et al., 2013b; Li et al., 2013; The et al., 2017;
Van Meter et al., 2014). In addition, the RE-mediated genomic instability has been associated
with the age-dependent decline in neuronal function seen in neurodegenerative diseases (Li
et al., 2013; Tan et al., 2011; The et al., 2017; reviewed in Dubnau, 2018; Erwin et al., 2014;
Gorbunova et al., 2014). However, it is still unclear whether RE expression is a causal agent or
a consequence of the age-dependent decline in neuronal function. In an attempt to clarify the
relationship between RE expression and the age-dependent decline in neuronal function, we
have constructed an unique heterologous RE system that allows the expression of a human L1
in a tissue-specific manner in D. melanogaster. We found out that forced expression of human
L1 in the fly neurons throughout lifespan does not a↵ect neuronal function. However, we did
not find any evidence supporting the ability of L1 to retrotranspose itself in cis, or a human
Alu in trans, in either DL2 cells or the fly CNS. Recent studies have shown that both human
and mice L1 remain capable of mediating retrotransposition when introduced into chicken
cells (Suzuki et al., 2009; Wallace et al., 2008a). Despite being warm-blooded vertebrates,
birds are evolutionary distant from mammals and do not encode homologues of the human
L1 in their genomes. As highlighted by Wagsta↵ et al. (2011), the work developed by Wallace
et al. (2008a) suggests that L1 (and Alu) retrotransposition would not require species-specific
interaction with additional host factors. Therefore, we hypothesized that if flies were able to
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transcribe and translate the bicistronic L1mRNA into correctly folded ORF1p and ORF2p, then
L1 retrotransposition would occur similarly in flies. In fact, previous research has demonstrated
that Drosophila cells are able to transcribe and translate human genes into functional proteins
(Krug et al., 2017). Furthermore, because L1 is extraneous to the surveillance mechanisms that
repress RE expression in D. melanogaster, L1 would not be repressed by these mechanisms. As
seen in Figure 3.1, Figure 3.3, and Figure 3.11, flies are indeed capable of transcribing and even
translating ORF2p, the second protein from the human L1 bicistronic transcript. However, the
forced expression of L1 in the fly neurons had no reproducible e↵ect on neuronal function as
determined by the negative geotaxis assay (Figure 3.2), thereby suggesting that this heterologous
system is not completely functional in D. melanogaster. This idea of an impaired system was
further corroborated by both in vitro retrotransposition assays (Figure 3.5 and Figure 3.11) and
in vivo experiments (Figure 3.6 and Figure 3.9). Taken together, the results herein obtained
suggest that the system built to study retrotransposition is nonfunctional and impaired at a
post-translational level since we were able to detect both L1 transcripts and ORF2p.
Several possible explanations for why the system does not work include piRNAs cross-
reaction, the high complexity of the developed system, gain of resistance against L1 and Alu
elements by the flies, acquisition of a mutation in any of the ORF1 and ORF2 sequences, and
requirement of additional factors in the retrotransposition process.
A reasonable explanation would be the cross-reaction of piRNAs. Albeit flies do not have a
L1 homologous element, they do have LINE-like elements that are targeted by piRNAs. There-
fore, it is possible that L1 and some of the LINE-like elements share conserved sequences and
as such, piRNAs targeting that conserved region could be cross-reacting, targeting L1, and me-
diating its silencing. However, as stated by Siomi et al. (2008), piRNAs are not detected in DL2
cells, and ergo, piRNA-mediated silencing would not explain why we were not able to detect
evidence of L1 activity in vitro.
Acquisition of resistance against the REs used in the retrotransposition system would be an
improbable justification for the system’s malfunction due to many reasons. Firstly, the main
mechanism through which L1 is repressed in the human is through DNA methylation of the
CpGs present in its promoter, however this mechanism of RE repression is absent in the flies.
Secondly, although studies have shown that Drosophila is able to acquire resistance against
TEs, that resistance is mediated by piRNAs (Vanssay et al., 2012). Therefore, for flies to ac-
quire resistance against L1 (or Alu), L1 elements would have to retrotranspose and reintegrate
within a piRNA cluster in the fly genome. Since L1 shows no preference for integration sites
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and the insertion in the genome is random, re-integration in a piRNA cluster would be infre-
quent. Besides, given that theUAS-L1 transgenic lines are maintained without GAL4 (Table 2.1),
the reintegration of L1 in a piRNA cluster in these lines is highly inconceivable because only
residual, if any, UAS-L1 is transcribed in the absence of GAL4.
Another possible explanation to consider is the occurrence of a mutation in either ORF1
or ORF2 genes, thereby interfering with the protein functions. The idea of a mutated ORF1
sequence can be rejected because it would not explain why the retrotransposition assay with
the pTub-Alu[Act-sfGFP] as a reporter failed, given that ORF2p has been reported to be su -
cient to mediate Alu retrotransposition (Figure 3.11) (Dewannieux et al., 2003; Wallace et al.,
2008a). Regarding ORF2p coding sequence, it is known that both endonuclease and reverse
transcriptase domains are crucial to mediate retrotransposition of both L1 and Alu (Moran et al.,
1996). Spontaneous mutations in D. melanogaster are rare and it would be even rarer to have
two mutations in both domains given their proximity (less than 1 kb) (Keightley et al., 2013).
Although the occurrence of a mutation in the endonuclease domain could explain why we did
not see an increase in the H2AV staining in DL2 cells or flies expressing L1 (Figure 3.5.B and
Figure 3.6.B), it is known that endonuclease-independent retrotransposition events do occur
and L1 can integrate itself (or Alu elements) in sites where there was a DSB (Morrish et al.,
2002). However, a mutation in the reverse transcriptase domain would also render the system
nonfunctional, hindering the retrotransposition of both L1 and Alu. Without this functionality,
the system would not function due to the incapability of reverse transcribing the retrotrans-
posons. Notwithstanding that mutations do occur at a very low frequency, it would be very
unlikely that all the plasmids, as well as the di↵erent flies used throughout the experiments,
would have accumulated mutations that would render them all nonfunctional. In fact, since
we are evaluating somatic transposition, all the cells in a fly would have a mutated L1, which
implicates that this mutation would have occurred in the fly germline and then transmitted to
the progeny, and by chance all the flies of the population would have inherited the mutated
allele. This would require many generations to occur, which makes it very unlikely given the
time of their existence.
Therefore, the results seem to point towards the idea that other factors besides L1 proteins
themselves might be involved in the retrotransposition process. Such factors would be present
in human, mouse, and chicken, but not in flies. It is becoming clearer that di↵erent host
factors are involved in L1 retrotransposition (Suzuki et al., 2009; Taylor et al., 2013; Taylor et al.,
2018). In the last two decades, several studies have been trying to unravel the L1 interactome
and it has been shown that the host factors seem to interact and interfere mostly with the L1
61
CHAPTER 4. DISCUSSION
RNP (Peddigari et al., 2013; Suzuki et al., 2009 Taylor et al., 2013; Taylor et al., 2018). Recent
research on L1 activity has shown that in order to successfully retrotranspose, L1 requires
phosphorylation of ORF1p (Cook et al., 2015). Cook et al. (2015) showed that although the non-
phosphorylation of ORF1p does not a↵ect the binding capacity of the protein, retrotransposition
of L1 is prevented. In the same study, the authors showed that phosphorylated ORF1p interacts
with a protein involved in cellular phosphorylation regulatory cascades (Cook et al., 2015). In a
di↵erent study performed with human cells, it was shown that L1 ORF2p requires the binding
of a specific host protein, polymerase-delta-associated sliding DNA clamp (PCNA) (Taylor et
al., 2013). By mutating ORF2 to prevent ORF2p of binding to PCNA, the authors noticed
that retrotransposition was decreased significantly. Downregulation of the protein also led to
the downregulation of L1 (Taylor et al., 2013). Given that di↵erent proteins interact with L1
throughout retrotransposition, it is conceivable that some of the interacting proteins might not
be present in D. melanogaster, resulting in the non-functionality of the system and explaining
why we were not able to detect successful retrotransposition events.
The reason why this work stands out from the other RNAi- and inhibitor-based studies
on REs and neurodegeneration is the fact that this system theoretically does not a↵ect the
function of other host proteins (Krug et al., 2017; The et al., 2017). However, this system
also has limitations. Firstly, flies and humans (or mammals in general) are evolutionarily very
distant, which might be translated in di↵erences in what concerns cellular factors between
these two organisms. In addition, there are no L1 nor Alu homologs in flies. Therefore, if L1
retrotransposition requires additional host factors, these might be lacking in flies. Secondly,
the L1 construct used in this work was codon-optimized for humans by Wagsta↵ et al. (2011).
Hence, di↵erences in the codon usage could hamper the translation e ciency of our constructs,
namely when in full length. Lastly, retrotransposition events are already rare in humans and
with the introduction of a human-optimized L1 into D. melanogaster genome, chances are that
the retrotransposition frequency decreases even more. Additionally, it could be that the absence
of detection of retrotransposition events in the fly CNS was due to the complexity and density
of the tissue, which would hinder the access of the antibody to the cells and, consequently, to
the target proteins. However, this is very unlikely since the samples were incubated with the
antibodies for at least 2 days to avoid that problem. In what concerns in vitro experiments, the
complexity of the LINE/SINE reporter system represents a great challenge to DL2 cells. The
system requires the use of three di↵erent plasmids (pAct-GAL4, pUAS-L1, and pTub-Alu[Act-
sfGFP], Table A.1, Appendix A) that must be incorporated by the same cell in order to be able
to detect a successful retrotransposition event. At the same time, the cells need to incorporate
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su cient number of plasmids to guarantee a detectable production of the plasmid products
(GAL4, AlumRNA and L1 ORF2p).
In conclusion, throughout this dissertation we have generated and used an inducible heterol-
ogous system to study the causal relationship between RE expression and neurodegeneration
in D. melanogaster. Our results revealed that forced expression of L1 may not be a cause of
the neuronal function decline associated with age. However, despite the several attempts, we
failed to show evidence supporting the functionality of our experimental system. Nevertheless,
this study showed that flies are able to transcribe and translate human-optimized L1 sequences
(reinforcing the idea that flies are a good alternative model - and more ethically recommended)
to study human gene expression. This study raised several questions and challenges for the
future such as: why is L1 unable to mediate retrotransposition in flies? Why can L1 retro-
transpose in chicken, but not in fly cells? How could we increase ORF2p translation e ciency
while maintaining ORF1p production? Can L1 retrotranspose in fish (zebrafish) or amphibians
(e.g., frogs)? Is L1 retrotransposition trully dependent on additional host factors? If so, what
are they? One thing is clear, L1 and TEs in general, are becoming more and more implicated
in the ageing process and in the development of sporadic form of neurodegenerative diseases.
Therefore, it is important to understand their role in these deteriorating processes and try to
find ways , if possible, to prevent, slow down, or mitigate the progress of these diseases.
In the future, we intend to clarify whether L1 is or not able to retrotranspose inD. melanogaster.
Therefore, it is important to guarantee that all the components of the built system function as
expected. Extraction of gDNA from UAS-L1 flies and sequencing of the L1 sequence, as well as
the use of an antibody that recognizes specifically a di↵erent region of the ORF2p, downstream
of the endonuclease domain as for instance an anti-reverse-transcriptase, would help in deter-
mining whether the proteins are truncated, mutated or fully functional. Although we have
used an anti-ORF2p which specifically binds to the endonuclease domain of the ORF2p, we are
aware that L1 has several weak transcriptional stop signals throughout its coding sequences,
which can often result in the formation of shortened transcripts carrying only the endonucle-
ase domain (Kines et al., 2014). It would also be important to investigate the L1 ORF2/Alu
in vivo, perform a negative geotaxis assay, and look for any phenotypic e↵ect in the neuronal
function decline associated with age. At the same time, the construction of a pUAS-L1 reporter
element would be important because it would lower the complexity of the reporter assay by
removing one plasmid, the SINE reporter element (pTub-Alu[Act-sfGFP]), from the transfection
conditions.
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In order to test our new hypothesis, that L1 requires additional factors to undergo retrotrans-
position, research on the di↵erences between the interactomes of L1 in human and DL2 cells via
immunoprecipitation procedures would help determining whether there are factors required
for L1 retrotransposition. We have seen that when cells were co-transfected with pUAS-ORF2
and pAct-GAL4, the intensity of moesin decreased. It would be interesting to see if di↵erent
concentrations of the pUAS-ORF2 plasmid have any e↵ect in the amount of moesin (or actin)
that is produced in the cell. Quantification of the protein could be achieved by performing
a Western Blot to quantify protein concentration. Moreover, we intend to inspect whether L1
ORF2p interacts or not with any of the actin cytoskeleton components, therefore disturbing its
dynamics.
Finally, to further investigate the role of REs in the neurofunctional decline associated
with age, it would be interesting to incorporate another organism (other arthropods, which are
evolutionarily close to D. melanogaster, or zebrafish) TEs in our system and look for evidence of
retrotransposition, and, if possible, look for an e↵ect in the neuronal function decline associated
with age.
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Table A.1: List of the plasmids used to inject the flies and to transfect DL2 cells.
Short name (ID) Name Size
(bp)
Origin
pAct-GAL4 pAC-Gal4 9094 Maria Dominguez’s
lab (CSIC-UMH)
pAct-sfGFP EcoRI-XbaI-AgeI-Act5pro-AgeI-sfGFP-
InvMhcInt16-XhoI-SV40polyA-NcoI-
NotI_in_pUC57
4549 Alisson Gontijo’s lab
(CEDOC)
pTub-Alu[Act-
sfGFP]
tub_prom-KpnI-AluYb8-AgeI-Act5pro-AgeI-
sfGFP-InvMhcInt16-XhoI-SV40polyA-NcoI-
AluYb8-AvrII-AgeI-PolyA-NotI_in_pCaSpeR4
12800 Alisson Gontijo’s lab
(CEDOC)
pUAS-GFP pJFRC-10xUAS-IVS-myr::GFP 8800 Addgene # 26222
pUAS-L1 pUASTN_L1(ORF1+2) 13832 Alisson Gontijo’s lab
(CEDOC)
pUAS-L1PA1 pBS-L1PA1-CH-mneo 11342 Addgene # 21588
pUAS-ORF2 pUASTN2-L1_ORF2 12843 Alisson Gontijo’s lab
(CEDOC)
pUASp-moesin pUASp-moesin::mCherry 11061 Alisson Gontijo’s lab
(CEDOC)
pUAST pUAST-empty 8900 Addgene # 24344
pUASTN pUASTN-empty 8900 Alisson Gontijo’s lab
(CEDOC)
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Figure A.1: Box plot with the anti-gravitational response of male control flies at 2, 20, and
40 days after eclosion. The anti-gravitational response was scored as the percentage of males
above (A, B) 2, (C, D) 4, and (D, E) 6 cm after (A,C,D) 5 s and (B, D, F) 10 s of the beginning of
the assay. Whiskers extend to the smallest and the largest value that are at most 1.5 times the
IQR (Tukey’s method). Black bars represent the median. Dots beyond whiskers are outliers.
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Table A.2: Statistical significance between the anti-gravitational response of di↵erent conditions (genotype and age) in the negative geotaxis assay
performed with UAS-L1a transgenic lines.
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57C10>: 2 d ns ns **** ns ns **** ns *** ****
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The locomotor capacity is scored as the % of males above the 6 cm mark, 5 s after initiating the assay. ns - p > 0.05; * - p  0.05; ** - p  0.01; *** - p  0.001; **** - p  0.0001;
Tukey’s multiple comparisons test. >L1 - UAS-L1a; pBDP> - pBDP-GAL4; 57C10> - 57C10-GAL4; nSyb> - nSyb-GAL4; elav> - elav-GAL4
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